TSS:Rfhg 72008.1

Basic information about the TSS

---

TSS ID: rfhg_72008.1 Species: human Chr: chr5		Start: 132937104 End: 132937124 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: CU687624:-69 CU693016:-69 GeneID: 27125 HGNC/MGI_ID: HGNC:17869 UniProt_ID: Nearer transcript ids and distances:

Gene_name: ALF transcription elongation factor 4 Gene_symbol: AFF4 Gene_synonyms: AF5Q31 MCEF Gene_source: HGNC:17869

TATA-Box annotation

---

Distance to TSS:	26520
Nearest PromoterID:	NM_014423
Entrez ID:	27125
Nearest Unigene:	Hs.519313
Nearest Refseq:	NM_014423
Nearest Ensembl:	ENSG00000072364
Gene Name:	ALF transcription elongation factor 4
Gene Alias:	AF5Q31|CHOPS|MCEF
Gene Type:	protein-coding
CpG%:	0.100000
GC%:	0.714286
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@AFF4 p2@AFF4 p3@AFF4 p4@AFF4 p5@AFF4 p6@AFF4 p7@AFF4
Sample		p1@AFF4	p2@AFF4	p3@AFF4	p4@AFF4	p5@AFF4	p6@AFF4	p7@AFF4
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	22.21	24.16	9.16	5.06	0.58	0.39	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	22.46	32.37	6.68	3.24	1.01	0.61	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	24.69	23.15	8.49	3.28	0.77	0.77	0.77
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	17.46	20.58	5.61	3.95	0.83	0.42	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	21.15	23.40	8.77	2.47	0.00	0.67	0.67
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	24.42	17.44	6.01	2.13	0.39	0.39	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	30.29	25.06	11.33	4.14	0.44	0.65	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	26.89	19.62	7.99	4.60	1.21	0.24	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	22.01	20.09	7.27	3.42	0.21	0.64	0.85
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	70.13	53.91	13.33	7.54	2.90	1.16	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	57.00	54.57	13.74	7.28	1.62	0.81	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	59.36	48.79	8.94	6.50	1.63	0.41	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	16.28	20.63	8.70	1.61	0.81	0.00	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	13.68	17.89	6.47	2.56	1.80	0.30	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	14.27	18.88	7.25	1.98	0.66	0.22	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	14.33	16.85	4.28	2.26	0.75	0.50	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	11.14	16.38	7.21	2.40	1.53	0.44	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	12.65	17.29	5.06	1.69	0.84	0.84	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	8.53	12.26	5.86	3.20	1.07	0.53	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	12.04	13.39	7.07	2.71	1.05	0.15	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	10.69	13.63	6.28	2.27	0.80	0.80	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	13.12	14.67	6.56	1.38	0.86	0.35	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	11.63	16.29	5.04	3.23	0.52	0.26	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	11.41	15.77	7.52	3.15	0.73	0.73	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	9.55	16.51	8.00	2.84	1.55	0.77	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	11.39	11.39	8.55	2.22	0.63	0.95	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	12.09	10.99	7.69	0.55	1.65	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	15.32	14.62	10.84	2.12	0.94	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	10.50	15.18	7.27	3.07	0.81	0.16	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	14.84	14.48	8.32	2.53	0.90	1.09	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	10.68	13.19	9.63	2.93	0.84	0.84	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	14.85	14.26	7.03	1.95	0.59	0.59	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	13.29	13.51	6.75	1.06	1.48	0.63	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	8.74	13.03	8.74	1.98	0.33	1.15	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	12.34	12.34	5.98	2.43	1.31	1.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	14.56	16.86	7.66	2.68	0.96	1.34	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	12.26	14.31	6.13	2.04	1.43	1.02	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	10.28	15.11	7.25	2.82	0.81	1.01	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	12.42	11.88	7.02	2.43	0.54	1.08	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	8.16	12.72	4.56	2.16	1.44	1.20	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	12.94	15.06	6.82	3.06	0.00	0.94	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	8.64	7.61	6.29	1.32	1.02	1.32	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	11.81	16.03	4.22	2.53	1.05	0.63	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	12.94	11.71	4.90	3.67	1.75	1.75	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	13.25	11.24	7.23	3.41	0.40	1.20	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	11.40	14.42	6.05	3.02	0.47	1.63	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	12.48	15.59	5.04	4.32	1.20	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	9.84	12.82	5.66	1.49	0.89	0.60	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	14.84	15.56	7.18	1.91	1.20	0.24	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	10.11	8.69	4.25	3.44	0.61	0.61	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	11.07	7.79	5.94	2.46	2.66	0.61	1.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	16.46	13.34	5.11	2.45	0.89	0.89	1.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00	0.00	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	9.58	11.36	4.97	2.48	0.71	1.77	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	7.62	10.27	5.30	1.99	2.32	0.33	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	5.87	5.87	4.19	0.84	0.84	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	6.89	3.21	5.51	0.00	3.67	0.92	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	11.34	7.45	6.16	1.62	1.30	0.32	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	8.99	13.17	7.07	2.89	0.96	1.28	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	5.34	6.60	4.09	1.57	1.26	0.00	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	11.28	11.99	5.64	2.82	0.00	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	10.09	16.82	3.93	2.24	1.12	1.12	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	7.17	15.92	5.57	1.59	4.78	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	4.08	5.44	2.38	0.34	3.40	1.02	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	11.05	15.27	3.90	0.97	1.30	0.00	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	8.16	11.36	7.45	4.26	1.06	0.35	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	15.79	0.00	23.69	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	8.78	13.16	7.80	1.95	0.49	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	9.92	10.91	7.93	1.98	0.00	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	3.75	7.97	5.63	2.35	0.94	0.47	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	3.64	6.29	6.62	0.66	0.66	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	8.35	12.06	7.11	0.62	0.93	0.31	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	6.73	11.92	5.50	1.53	0.92	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	13.62	12.83	7.92	2.53	0.48	0.48	0.32
Adipocyte - breast, donor2	11327-117E4	11.07	14.28	6.42	1.76	0.00	0.96	0.32
Adipocyte - omental, donor1	11473-119C6	17.05	16.92	7.63	2.67	1.02	1.40	0.89
Adipocyte - omental, donor2	11474-119C7	5.98	2.99	2.24	0.00	0.00	1.49	0.00
Adipocyte - omental, donor3	11475-119C8	13.06	11.39	2.68	2.34	0.00	1.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	10.85	6.38	1.28	2.55	0.00	0.00	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	3.30	4.40	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	0.90	6.32	1.35	1.81	0.45	0.45	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	4.69	7.47	2.43	0.70	0.17	0.70	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	18.58	23.27	11.93	3.91	0.78	0.78	0.98
Adipocyte differentiation, day04, donor2	13022-139D7	17.50	17.50	9.27	3.86	0.77	0.51	1.03
Adipocyte differentiation, day04, donor3	13025-139E1	12.54	11.43	7.81	1.67	0.56	1.12	1.12
Adipocyte differentiation, day04, donor4	13028-139E4	16.46	21.75	7.05	4.11	2.35	0.00	1.76
Adipocyte differentiation, day08, donor1	13020-139D5	13.59	19.55	10.62	2.01	1.05	0.48	0.56
Adipocyte differentiation, day08, donor2	13023-139D8	14.52	11.30	9.36	3.55	1.29	0.65	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	9.06	13.86	10.13	3.20	0.00	1.60	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	9.46	11.13	6.68	2.23	2.23	0.56	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	8.32	9.15	3.74	3.33	0.00	1.25	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	8.79	8.54	6.53	1.00	0.50	0.75	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	14.40	10.14	6.22	2.29	0.33	1.31	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	10.05	9.74	7.92	2.44	0.30	0.61	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	5.08	6.63	2.87	1.10	0.00	0.22	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	3.59	2.15	0.72	0.36	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	2.40	2.40	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	6.84	9.36	4.32	1.08	1.44	0.36	0.90
Amniotic Epithelial Cells, donor2	11613-122A2	5.02	1.67	5.02	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	4.73	8.01	4.31	1.03	0.82	0.41	0.00
Anulus Pulposus Cell, donor1	11248-116E6	12.36	10.98	5.72	3.89	0.57	0.11	0.57
Anulus Pulposus Cell, donor2	11463-119B5	10.78	8.08	2.94	6.37	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	6.29	7.19	2.25	3.59	0.45	1.35	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	4.78	4.34	3.04	3.04	1.30	0.43	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	6.42	6.42	4.28	0.00	2.14	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	8.97	7.47	4.18	2.99	0.30	0.30	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	7.59	6.32	2.53	1.26	0.00	1.26	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	4.62	6.60	3.30	1.98	0.00	1.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	6.50	5.52	1.62	1.62	0.97	0.32	1.62
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	4.85	7.77	2.91	0.00	0.49	0.00	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	4.75	4.75	3.56	0.00	0.59	0.59	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	3.01	4.52	2.64	1.13	1.13	0.75	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	7.26	5.81	3.63	2.90	0.00	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	3.76	5.02	3.76	2.51	0.00	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	8.90	12.68	7.41	3.46	1.15	0.66	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	4.09	8.19	2.73	2.73	0.00	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	5.43	7.09	2.26	0.90	1.21	0.90	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	6.43	2.68	2.68	1.61	0.00	0.00	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	5.48	5.48	3.21	1.70	0.57	0.38	1.13
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	8.82	9.09	5.08	1.07	0.27	0.53	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	5.85	5.85	3.90	0.98	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	6.30	7.46	3.98	0.83	1.16	0.66	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	3.60	10.81	1.20	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	3.54	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	7.03	5.66	4.46	1.37	0.51	0.86	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	0.00	4.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	2.43	4.85	1.46	0.49	0.97	1.46	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	6.83	5.31	2.28	0.76	1.90	1.14	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	7.27	4.85	0.00	1.21	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	5.70	6.27	2.28	1.71	1.14	0.00	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	5.34	6.84	3.63	2.14	1.28	0.86	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	8.00	5.68	2.06	1.81	1.29	1.03	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	4.22	2.82	2.82	1.41	0.94	0.00	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	7.07	8.36	1.61	1.61	0.96	0.64	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	9.27	4.28	3.57	2.85	0.71	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	6.43	4.68	4.68	1.75	0.00	0.00	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	8.73	4.82	3.31	2.11	0.90	0.90	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	5.94	8.32	0.00	1.19	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	3.56	6.10	4.58	0.51	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	6.62	6.11	5.86	2.04	1.02	0.76	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	5.72	2.54	4.45	0.64	0.64	1.27	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	9.49	5.18	3.02	1.29	1.73	0.86	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	5.29	5.29	3.39	1.06	0.64	0.64	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	5.22	4.93	2.61	1.45	0.58	0.29	0.87
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	3.78	4.72	0.94	0.00	0.94	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	7.97	5.93	3.22	1.53	1.02	0.34	1.02
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	2.32	2.32	11.58	0.00	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	8.45	0.00	2.11	2.11	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	8.36	6.22	2.36	1.07	0.43	0.21	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	3.01	5.41	4.21	3.01	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	2.19	5.83	2.92	2.19	0.00	0.00	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	6.67	6.90	2.53	2.07	0.69	0.92	0.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	10.20	12.75	10.20	2.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	5.34	6.10	4.58	0.76	0.76	0.76	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	8.05	9.70	4.54	1.03	1.24	0.62	1.03
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	9.49	8.57	3.98	2.14	0.31	0.00	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	7.17	4.78	2.39	1.91	0.48	0.96	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	7.10	6.65	5.10	1.55	2.00	0.67	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	7.63	9.15	1.53	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	6.09	3.88	2.22	1.11	0.55	0.55	2.22
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	7.41	7.41	4.24	1.32	0.79	0.53	0.79
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	7.27	7.63	6.54	0.36	1.09	0.36	1.45
Astrocyte - cerebellum, donor1	11500-119F6	9.33	9.33	1.35	3.56	0.25	0.86	0.61
Astrocyte - cerebellum, donor2	11580-120F5	7.36	6.85	0.86	3.25	0.34	0.17	0.51
Astrocyte - cerebellum, donor3	11661-122F5	6.92	6.92	2.52	2.94	0.21	0.21	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	27.54	30.33	6.97	4.53	2.09	0.70	2.44
Astrocyte - cerebral cortex, donor2	11316-117D2	23.30	23.30	11.49	4.53	1.46	0.32	0.81
Astrocyte - cerebral cortex, donor3	11392-118C6	27.89	28.64	9.25	5.37	1.64	0.30	1.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	11.01	11.12	9.17	2.06	1.15	0.92	0.46
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	10.77	7.02	5.26	2.76	1.25	0.25	0.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	9.67	6.83	6.37	2.62	0.68	0.34	0.23
Basophils, donor1	12241-129G9	10.20	17.00	28.51	3.14	0.52	2.35	0.00
Basophils, donor2	12242-129H1	21.29	19.48	37.88	4.33	1.80	1.08	1.80
Basophils, donor3	12243-129H2	8.53	17.79	34.25	2.20	0.44	1.76	0.88
Bronchial Epithelial Cell, donor1	11511-119G8	2.37	6.90	3.02	0.43	0.43	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	2.29	2.74	0.00	0.46	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	7.17	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	4.39	1.88	1.88	1.26	1.88	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	4.99	4.78	2.08	0.83	1.04	1.04	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	4.84	7.60	2.07	0.23	0.23	0.46	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	5.22	9.00	3.78	0.54	0.18	0.36	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	11.95	8.66	4.74	2.47	0.62	0.00	0.93
Burkitt's lymphoma cell line:RAJI	10476-106I8	12.58	9.78	8.38	3.03	2.33	0.23	2.33
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	14.39	9.27	7.99	8.31	3.52	0.32	3.52
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	41.37	41.37	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	14.09	32.12	52.97	1.13	1.69	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	18.93	30.25	48.63	6.31	1.48	0.93	0.93
CD14+ Monocytes, donor3	11381-118B4	16.03	28.10	53.35	4.17	1.54	1.76	0.88
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	11.89	14.44	25.47	1.42	1.98	0.28	1.13
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	15.92	17.82	21.61	5.69	3.41	0.00	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	17.75	23.01	31.23	1.97	1.97	0.00	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	18.50	24.14	36.86	1.30	1.16	1.73	0.58
CD14+ monocytes - mock treated, donor2	11873-125C1	19.01	27.76	32.59	1.21	1.51	2.41	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	16.82	22.50	34.11	2.37	0.71	1.90	2.13
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	19.75	28.46	40.34	0.84	0.84	2.68	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	29.53	35.61	36.99	2.48	0.55	3.59	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	28.76	36.45	51.82	2.23	2.73	2.73	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	20.36	22.32	38.96	0.98	0.00	1.37	0.59
CD14+ monocytes - treated with BCG, donor2	11870-125B7	20.83	33.30	43.80	2.14	0.53	3.56	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	23.94	29.82	46.57	0.65	0.44	2.18	0.65
CD14+ monocytes - treated with Candida, donor1	11868-125B5	22.94	35.12	45.19	2.81	0.47	3.75	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	39.07	43.30	42.24	2.11	1.06	5.28	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	26.62	26.62	52.14	3.33	0.00	5.55	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	16.51	24.69	41.05	1.49	0.74	2.23	0.45
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	16.76	24.74	36.12	1.20	0.80	4.19	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	15.61	19.36	32.90	2.29	1.04	2.29	1.25
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	16.01	28.14	38.44	1.60	2.52	1.60	0.92
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	26.69	29.86	47.73	2.71	2.04	3.62	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	24.01	24.01	44.52	3.93	1.31	5.24	1.31
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	14.26	20.44	30.93	1.08	0.54	1.34	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	20.76	29.48	45.71	2.27	0.87	3.31	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	23.57	28.62	38.72	1.68	1.68	2.52	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	17.27	31.97	43.17	0.92	0.55	2.94	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	25.72	34.87	42.27	2.47	1.06	2.47	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	31.15	38.17	44.31	1.32	0.44	7.90	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	28.07	33.31	43.42	2.09	0.70	2.62	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	23.42	33.82	40.51	0.74	1.12	4.09	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	30.39	40.31	50.01	1.08	1.51	4.10	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	23.75	32.35	28.66	2.05	0.00	2.87	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	37.32	35.23	44.74	1.16	0.00	3.71	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	22.04	27.38	42.22	1.39	0.23	2.78	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	5.01	8.28	14.60	0.87	0.65	0.44	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	6.01	9.47	21.02	1.62	0.69	0.69	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	4.98	8.45	11.05	1.52	0.43	0.43	0.65
CD14+CD16- Monocytes, donor1	11788-124B6	9.65	21.18	45.47	2.18	1.25	0.62	0.62
CD14+CD16- Monocytes, donor2	11799-124C8	7.34	14.15	29.17	1.40	0.52	0.52	0.70
CD14+CD16- Monocytes, donor3	11910-125G2	11.59	22.74	39.47	1.34	1.78	0.67	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	5.10	10.72	22.46	2.04	0.77	1.28	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	7.25	10.32	17.35	1.32	1.32	1.32	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	7.58	7.79	15.16	0.84	0.42	0.84	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	32.52	18.29	12.19	10.16	8.13	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	31.86	18.98	19.66	6.78	1.36	1.36	3.39
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	20.71	13.46	20.71	9.32	1.04	3.11	3.11
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	36.78	25.59	14.93	11.19	3.73	2.13	2.67
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	28.41	23.59	12.33	10.72	2.68	1.61	1.61
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	23.87	18.95	9.13	9.13	3.51	2.81	1.40
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	28.24	13.33	10.20	10.98	1.57	0.78	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	27.68	22.41	13.18	11.86	6.59	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	87.12	47.67	25.48	20.55	4.11	9.04	5.75
CD19+ B Cells, donor2	11624-122B4	47.15	42.07	31.19	19.59	0.00	2.90	2.90
CD19+ B Cells, donor3	11705-123B4	66.13	50.48	35.34	22.21	3.03	8.08	5.05
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	14.95	11.72	5.25	4.44	0.00	0.00	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	10.39	5.59	1.60	2.80	0.40	0.00	0.40
CD34+ Progenitors, donor1	11545-120B6	19.08	20.08	26.11	7.03	1.00	0.00	8.03
CD34+ Progenitors, donor2	11625-122B5	19.66	16.29	15.17	7.30	2.81	0.00	1.69
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	7.89	6.76	4.88	4.51	0.75	0.38	1.50
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	9.92	8.57	5.86	5.19	0.68	0.00	0.45
CD4+ T Cells, donor1	11225-116C1	84.62	36.78	28.56	57.84	12.50	7.14	6.07
CD4+ T Cells, donor2	11306-117C1	69.81	23.27	15.31	57.56	9.80	4.90	1.84
CD4+ T Cells, donor3	11382-118B5	47.88	18.60	14.33	31.72	4.27	7.93	1.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	18.63	8.93	4.59	11.74	4.85	1.02	2.55
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	23.13	7.86	4.94	12.58	4.72	2.02	2.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	24.43	12.07	7.76	8.91	6.04	1.44	2.01
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	35.08	16.59	10.90	27.50	4.27	5.22	2.84
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	40.03	15.45	8.43	29.50	8.43	2.11	4.21
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	52.74	9.89	6.59	19.78	3.30	19.78	6.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	15.61	10.12	6.07	6.79	4.05	0.58	2.02
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	17.79	11.35	5.76	8.98	2.54	0.68	1.36
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	17.73	7.74	3.71	11.28	3.06	2.26	1.45
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	21.52	7.62	4.93	12.55	1.79	2.69	1.34
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	21.66	10.13	7.69	13.28	2.80	1.75	2.10
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	29.48	9.24	7.04	14.52	2.20	3.52	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	18.97	13.07	5.48	9.28	4.22	0.42	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	16.83	7.27	6.03	4.99	3.12	0.62	0.83
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	13.37	7.35	4.01	5.68	2.00	1.34	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	65.26	16.59	8.43	50.85	3.54	4.35	4.08
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	65.39	16.61	6.97	55.74	7.50	1.61	2.14
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	59.18	16.14	7.17	48.42	3.59	1.79	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	17.80	15.02	6.86	9.27	4.26	0.74	1.85
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	19.28	9.75	4.33	9.31	2.82	0.65	1.08
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	20.38	16.81	8.62	12.61	3.15	0.63	2.52
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	34.89	12.64	8.60	28.82	2.02	5.56	2.02
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	36.39	14.30	6.93	20.80	3.03	0.87	2.17
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	47.50	16.13	11.77	24.41	4.79	2.18	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	38.60	8.91	10.89	20.29	4.95	1.98	1.48
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	26.77	7.39	8.31	17.54	2.77	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	26.52	6.98	5.58	22.33	4.19	4.19	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	38.49	12.46	3.05	21.88	3.32	3.60	2.77
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	35.09	9.08	3.68	22.09	2.45	2.45	3.19
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	38.50	20.02	9.24	27.72	7.70	3.08	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	34.02	15.76	8.95	20.41	3.94	1.79	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	29.08	9.69	9.69	11.08	6.92	2.77	4.15
CD8+ T Cells, donor1	11226-116C2	45.84	38.63	33.39	24.23	3.93	10.15	1.64
CD8+ T Cells, donor2	11307-117C2	44.68	31.54	30.03	18.40	2.25	6.01	3.75
CD8+ T Cells, donor3	11383-118B6	59.59	29.79	29.29	36.61	3.79	7.32	2.27
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	4.36	5.96	5.96	1.84	0.92	0.00	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	5.51	5.03	5.27	2.16	1.20	0.24	1.20
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	3.56	3.01	6.02	0.55	1.64	0.82	0.82
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	4.50	3.90	7.51	1.50	0.60	0.30	1.20
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	5.04	6.00	6.48	0.96	0.96	0.48	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	5.46	6.37	7.73	0.68	0.91	0.45	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	4.13	4.35	9.13	0.87	1.09	0.22	1.30
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	3.95	6.32	7.11	0.53	1.84	0.26	1.32
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	6.10	5.16	7.04	1.64	0.70	0.70	0.94
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	3.32	6.04	6.34	1.81	1.51	0.30	0.91
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	6.10	4.65	7.55	2.32	1.45	0.29	1.16
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	2.13	5.06	9.06	1.33	1.33	0.27	1.87
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	17.51	24.51	22.76	1.31	3.50	0.44	1.75
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	15.03	14.57	27.78	3.19	5.01	0.46	4.55
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	23.87	26.11	38.04	6.71	4.48	0.75	3.73
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	8.28	5.40	6.84	1.08	1.08	0.00	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	4.60	4.89	5.75	0.00	0.58	0.00	1.15
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	3.77	4.24	8.01	0.47	0.24	0.47	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	7.29	5.39	9.51	1.27	1.27	0.63	1.27
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	4.31	4.92	7.69	0.92	1.23	0.62	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	5.45	3.85	12.18	1.92	1.92	0.32	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	7.65	6.50	9.94	0.38	0.76	0.00	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	3.55	7.49	13.40	0.39	0.79	0.39	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	2.27	2.27	8.32	1.51	1.51	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	39.34	54.60	54.60	2.41	5.62	0.80	2.41
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	47.56	54.56	67.84	5.60	5.60	0.70	6.99
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	37.06	57.10	65.11	3.01	7.01	1.00	6.01
Cardiac Myocyte, donor1	11525-119I4	1.83	9.14	3.66	3.66	3.66	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	6.92	12.35	4.45	4.45	0.99	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	9.26	12.10	5.68	1.37	0.84	0.00	0.21
Chondrocyte - de diff, donor1	11261-116G1	12.48	6.93	3.12	2.43	0.00	0.35	0.00
Chondrocyte - de diff, donor2	11338-117F6	7.46	10.31	7.46	1.42	0.00	0.71	0.71
Chondrocyte - de diff, donor3	11410-118E6	10.92	13.65	6.94	1.14	0.80	0.57	0.34
Chondrocyte - re diff, donor2	11339-117F7	12.53	15.22	13.43	4.48	0.00	0.90	0.90
Chondrocyte - re diff, donor3	11411-118E7	13.75	19.41	17.79	1.21	1.21	3.24	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	23.87	30.41	14.69	5.85	2.41	0.46	1.61
Ciliary Epithelial Cells, donor2	11323-117D9	22.02	22.87	11.76	5.56	1.92	1.28	1.07
Ciliary Epithelial Cells, donor3	11399-118D4	21.33	27.26	13.89	4.16	2.21	1.33	1.50
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	28.34	22.01	13.85	10.73	0.83	7.15	0.83
Corneal Epithelial Cells, donor1	11526-119I5	1.98	1.98	1.54	0.22	0.00	0.66	0.00
Corneal Epithelial Cells, donor2	11606-120I4	2.28	5.69	6.83	0.00	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	4.86	7.16	3.07	0.51	0.26	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	6.60	11.23	19.32	0.66	0.66	0.17	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	9.15	11.67	19.87	0.63	0.32	0.32	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	13.80	10.35	6.90	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	5.51	7.34	14.15	0.43	0.76	0.11	0.43
Dendritic Cells - plasmacytoid, donor1	11228-116C4	34.16	31.09	33.14	26.31	1.37	1.02	3.07
Dendritic Cells - plasmacytoid, donor2	11309-117C4	22.20	18.28	19.59	11.75	3.92	1.31	2.61
Dendritic Cells - plasmacytoid, donor3	11385-118B8	27.10	13.55	16.45	12.58	1.94	0.48	1.94
Endothelial Cells - Aortic, donor0	11207-116A1	6.50	10.01	11.17	1.50	3.00	0.17	1.33
Endothelial Cells - Aortic, donor1	11263-116G3	1.76	3.52	2.93	0.00	1.76	0.00	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	7.35	9.90	3.39	1.98	2.55	0.00	1.13
Endothelial Cells - Aortic, donor3	11412-118E8	11.40	14.94	7.47	3.54	2.75	0.00	0.79
Endothelial Cells - Artery, donor1	11264-116G4	5.82	4.94	2.91	2.62	0.87	0.00	1.16
Endothelial Cells - Artery, donor2	11341-117F9	6.59	7.76	5.88	1.65	2.59	0.00	0.94
Endothelial Cells - Artery, donor3	11413-118E9	6.49	8.06	5.96	0.88	1.75	0.35	0.70
Endothelial Cells - Lymphatic, donor1	11236-116D3	10.20	11.75	9.09	2.88	1.77	0.22	0.89
Endothelial Cells - Lymphatic, donor2	11317-117D3	11.56	14.91	9.74	2.74	4.56	0.00	2.74
Endothelial Cells - Lymphatic, donor3	11393-118C7	14.94	18.61	9.58	1.69	7.33	0.28	1.97
Endothelial Cells - Microvascular, donor1	11265-116G5	4.46	6.24	3.86	0.59	0.89	0.30	1.19
Endothelial Cells - Microvascular, donor2	11342-117G1	3.64	7.29	4.69	1.56	1.04	0.00	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	4.96	6.95	4.25	0.71	1.99	0.14	1.13
Endothelial Cells - Thoracic, donor1	11266-116G6	11.60	10.40	4.00	2.40	1.60	0.00	2.40
Endothelial Cells - Thoracic, donor2	11343-117G2	4.19	8.91	3.67	0.00	1.05	0.52	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	13.29	19.38	16.52	3.35	6.21	0.50	1.24
Endothelial Cells - Umbilical vein, donor2	11324-117E1	11.08	18.90	10.86	3.04	4.56	0.22	1.30
Endothelial Cells - Umbilical vein, donor3	11400-118D5	14.66	18.93	10.87	2.69	5.50	0.12	1.34
Endothelial Cells - Vein, donor1	11267-116G7	3.41	4.55	4.55	0.00	1.14	2.28	0.00
Endothelial Cells - Vein, donor2	11344-117G3	4.19	6.99	5.59	2.10	4.19	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	8.64	10.99	6.44	0.63	2.67	0.31	0.79
Eosinophils, donor1	12244-129H3	30.49	0.00	0.00	0.00	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	33.01	47.86	125.42	6.60	1.65	4.95	0.00
Eosinophils, donor3	12246-129H5	49.94	42.80	117.71	7.13	0.00	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	2.69	3.91	2.44	0.00	0.24	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	2.08	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	11.08	16.01	9.03	1.64	1.23	1.23	1.23
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	4.82	8.43	3.18	1.53	0.66	0.99	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	9.10	9.86	3.68	1.63	0.43	0.65	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	12.61	15.04	9.58	2.06	1.09	0.61	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	20.06	36.57	23.88	2.73	2.32	3.14	0.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	10.86	12.02	6.22	2.53	0.95	0.53	0.42
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	20.03	17.92	10.80	2.37	0.53	1.32	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	15.95	15.28	9.97	3.32	0.33	1.99	0.66
Fibroblast - Cardiac, donor1	11268-116G8	9.53	11.34	3.18	4.08	2.27	0.45	0.91
Fibroblast - Cardiac, donor2	11345-117G4	10.61	8.34	6.82	2.27	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	6.15	7.57	6.47	1.73	0.32	0.00	0.47
Fibroblast - Cardiac, donor4	11452-119A3	18.79	27.28	14.25	5.76	1.82	0.00	1.21
Fibroblast - Cardiac, donor5	11456-119A7	9.64	9.64	5.46	2.03	1.52	0.13	1.02
Fibroblast - Cardiac, donor6	11460-119B2	9.10	8.19	4.09	2.58	1.21	0.15	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	14.20	11.39	2.55	3.48	0.54	0.40	0.67
Fibroblast - Choroid Plexus, donor2	11572-120E6	13.81	17.26	6.04	3.88	1.29	0.43	2.59
Fibroblast - Choroid Plexus, donor3	11653-122E6	8.79	5.86	4.39	0.00	1.46	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	6.46	10.38	3.92	1.61	0.69	0.00	0.69
Fibroblast - Conjunctival, donor3	11692-122I9	14.42	12.55	6.78	7.46	2.04	0.51	0.85
Fibroblast - Dermal, donor1	11269-116G9	5.87	8.92	6.10	1.41	1.64	0.23	0.70
Fibroblast - Dermal, donor2	11346-117G5	5.19	4.72	2.83	1.42	0.94	0.00	0.47
Fibroblast - Dermal, donor3	11418-118F5	4.35	6.17	9.67	0.85	0.36	0.73	0.24
Fibroblast - Dermal, donor4	11450-119A1	12.32	10.97	3.73	3.28	0.79	0.23	0.23
Fibroblast - Dermal, donor5	11454-119A5	10.29	11.69	4.01	3.14	0.70	0.17	0.70
Fibroblast - Dermal, donor6	11458-119A9	11.86	9.42	3.90	1.62	2.27	0.16	0.49
Fibroblast - Gingival, donor1	11237-116D4	10.41	17.07	10.83	4.37	2.92	0.42	1.25
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	23.32	22.53	13.10	3.67	0.79	0.52	1.31
Fibroblast - Gingival, donor2	11318-117D4	10.67	9.62	6.06	1.98	1.98	0.13	0.92
Fibroblast - Gingival, donor3	11394-118C8	19.14	27.17	13.83	4.25	0.87	0.87	0.48
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	18.70	24.93	19.74	3.12	1.04	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	13.04	18.85	12.69	2.82	0.35	1.76	0.88
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	18.55	18.08	13.72	4.21	3.43	0.31	0.78
Fibroblast - Gingival, donor6 (control)	11922-125H5	14.06	13.25	10.28	2.43	2.57	0.54	0.81
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	83.28	91.75	28.94	13.41	3.53	4.59	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	19.74	19.60	9.65	5.41	1.17	0.73	1.32
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	17.18	12.14	10.09	3.41	1.91	1.77	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	23.04	16.02	15.47	5.16	1.43	0.88	0.77
Fibroblast - Gingival, donor9 (control)	11927-125I1	25.09	23.18	9.24	7.04	1.17	0.88	1.17
Fibroblast - Lung, donor1	11270-116H1	5.44	8.16	0.00	1.36	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	11.94	14.92	2.98	2.98	2.98	2.98	1.49
Fibroblast - Lung, donor3	11419-118F6	7.39	9.29	8.65	1.69	1.69	0.42	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	10.83	1.67	1.67	0.00	0.00	1.67	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	2.80	8.39	2.80	0.00	1.40	2.80	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	3.92	4.76	1.96	0.56	0.28	0.56	0.00
Fibroblast - Mammary, donor1	11540-120B1	9.74	16.24	5.28	2.03	0.41	0.41	0.41
Fibroblast - Mammary, donor2	11620-122A9	0.00	0.00	0.00	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	0.00	5.96	5.96	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	11.44	15.52	8.53	2.52	2.13	0.00	0.58
Fibroblast - Periodontal Ligament, donor2	11319-117D5	19.42	17.90	10.16	6.07	3.03	0.15	0.61
Fibroblast - Periodontal Ligament, donor3	11395-118C9	23.56	28.46	13.46	2.45	3.37	0.61	1.22
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	14.50	11.07	12.21	3.82	1.14	1.14	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	11.07	13.50	12.42	1.62	1.35	0.54	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	17.86	24.82	12.87	4.06	0.81	1.51	0.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	7.18	9.17	9.06	1.66	0.77	0.22	0.77
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	7.11	12.60	8.33	1.42	0.61	0.20	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	4.68	6.68	0.67	0.67	0.00	0.00	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	5.54	7.12	3.95	1.98	0.40	0.00	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	21.43	18.26	12.70	4.37	0.60	1.39	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	10.83	12.43	7.82	2.49	0.00	0.53	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	13.01	13.80	12.42	2.76	0.59	0.39	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	14.14	11.13	9.03	1.20	0.30	0.90	0.90
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	11.23	17.92	6.37	2.91	0.97	0.54	0.86
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	23.28	19.74	10.38	3.80	0.76	1.01	0.51
Fibroblast - skin normal, donor1	11553-120C5	9.19	11.65	6.07	1.80	0.49	1.15	0.66
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	18.65	21.25	24.66	3.61	2.21	0.80	1.00
Fibroblast - skin normal, donor2	11561-120D4	12.06	12.36	4.72	2.61	0.50	0.40	0.40
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	24.18	19.04	9.67	3.63	1.51	0.30	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	14.50	15.82	11.35	3.65	0.58	0.99	0.33
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	15.73	11.80	3.59	4.10	0.34	1.03	1.54
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	20.03	13.47	10.51	2.96	0.33	0.00	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	9.05	12.57	3.73	2.45	1.17	0.53	0.53
Fibroblast - skin walker warburg, donor1	11554-120C6	9.61	11.13	5.74	2.36	1.35	0.34	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	4.08	4.23	3.76	0.78	0.94	0.47	0.47
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	22.16	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	18.30	20.05	16.56	1.74	3.49	2.61	2.61
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	12.48	16.99	13.18	2.08	2.08	1.21	1.39
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	15.61	17.18	16.66	2.34	3.12	0.78	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	16.35	24.27	12.52	3.83	4.09	2.04	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	18.37	13.01	2.30	9.19	0.77	1.53	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	12.76	12.76	1.28	2.55	0.64	0.64	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	21.11	15.12	4.56	5.99	1.71	1.43	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	49.08	35.85	9.10	12.96	1.10	0.55	1.65
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	29.45	23.52	3.42	7.76	1.37	0.91	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	33.88	24.37	4.76	8.12	1.19	1.39	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	48.11	38.59	7.14	13.75	0.79	0.26	1.32
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	39.14	23.81	5.87	8.15	0.33	0.65	3.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	20.78	12.82	3.98	7.96	2.65	1.33	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	27.13	17.67	6.22	7.91	1.41	0.14	1.98
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	30.91	26.35	6.16	7.63	1.48	0.12	1.72
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	25.79	16.65	5.64	6.45	2.42	0.00	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	26.51	26.02	9.79	5.70	1.49	0.37	0.99
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	31.84	24.92	10.80	7.34	3.05	0.28	1.66
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	22.97	18.70	7.32	6.30	2.03	0.41	1.02
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	23.73	22.59	8.67	6.85	1.83	0.23	1.14
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	28.53	23.29	6.85	6.23	1.62	0.12	0.75
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	40.66	29.29	14.21	9.18	3.06	0.22	1.75
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	23.64	23.05	8.57	5.32	2.07	0.00	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	24.48	28.14	6.52	6.36	1.27	0.16	0.95
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	33.07	23.91	8.04	7.60	1.56	0.45	1.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	20.57	20.97	7.66	3.63	1.41	0.00	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	21.71	20.70	7.29	6.79	1.36	0.34	1.02
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	37.60	32.63	11.97	7.71	4.52	0.80	1.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	31.22	34.65	11.24	6.14	2.71	0.00	1.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	22.37	26.30	8.88	5.64	2.05	0.51	1.88
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	23.02	28.22	8.08	6.42	1.44	0.00	1.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	24.38	27.79	8.65	6.99	1.91	0.17	0.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	25.93	17.97	7.76	4.90	2.04	0.00	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	17.54	22.28	6.40	3.92	1.44	0.00	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	24.44	28.94	7.96	3.80	1.38	0.00	1.50
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	21.35	21.18	11.17	3.34	1.33	0.00	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	17.63	25.35	5.51	2.42	0.22	0.00	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	24.84	26.57	9.22	4.92	0.98	0.12	0.61
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	23.18	23.50	9.40	5.02	1.62	0.16	0.81
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	27.90	26.30	11.23	3.53	0.96	0.32	1.92
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	18.76	24.35	7.20	3.70	0.76	0.00	1.14
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	19.30	20.25	6.01	4.90	1.11	0.00	0.95
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	22.50	20.37	11.56	2.43	1.22	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	20.80	22.68	7.84	4.39	1.57	0.10	1.67
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	22.83	21.08	10.10	3.95	1.32	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	21.04	25.53	10.94	5.05	2.52	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	17.22	27.68	12.78	6.30	2.69	0.37	1.02
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	18.18	16.04	6.69	1.60	1.87	0.00	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	19.74	23.41	12.55	3.98	2.45	0.31	1.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	14.90	21.89	8.29	3.89	0.91	0.00	1.42
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	13.82	24.13	10.57	2.17	1.36	0.81	1.08
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	15.49	24.15	7.19	4.06	2.40	0.37	0.92
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	21.71	23.69	7.02	5.04	1.54	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	44.63	71.41	8.93	9.92	2.98	0.99	2.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	15.96	26.38	9.89	3.17	1.71	0.13	1.06
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	14.53	22.60	11.30	2.62	1.21	0.20	1.21
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	34.31	53.88	21.60	3.81	2.54	0.25	2.80
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	18.31	13.54	1.39	6.17	1.99	0.40	1.79
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	20.95	20.65	7.24	8.32	1.69	0.31	0.62
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	24.14	22.09	5.73	10.23	2.66	0.41	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	11.27	11.27	2.19	3.44	0.31	0.00	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	6.78	6.50	2.26	1.98	0.85	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	10.61	10.15	2.77	6.46	0.92	0.00	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	2.47	12.37	4.95	14.85	0.00	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	18.57	9.28	4.64	6.58	1.16	0.39	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	16.04	12.84	3.21	4.81	1.60	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	20.87	26.08	0.00	3.48	1.74	1.74	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	14.65	10.42	2.93	7.49	1.30	0.00	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	18.12	9.88	4.53	3.29	1.24	0.00	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	49.98	36.65	3.33	13.33	3.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	18.46	12.86	2.80	3.92	0.84	0.84	1.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	15.69	15.03	1.96	4.58	1.63	0.00	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	29.36	33.55	0.00	6.71	0.84	0.00	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	25.13	16.86	5.09	7.95	0.95	0.00	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	14.27	9.51	2.38	2.38	1.36	0.00	1.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	12.53	16.71	6.26	6.26	0.00	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	20.62	12.03	3.44	4.01	0.57	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	9.77	8.58	2.07	4.14	0.00	0.00	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	13.55	27.11	1.69	3.39	0.00	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	19.05	10.36	3.31	2.49	2.07	0.41	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	19.56	14.04	3.68	3.45	1.61	0.23	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	5.27	36.88	5.27	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	18.07	10.76	2.69	3.84	1.15	0.77	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	14.99	16.30	4.89	4.89	0.33	0.00	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	16.05	19.40	2.01	4.68	0.67	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	24.27	17.34	3.47	5.01	1.54	0.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	35.60	25.68	5.48	8.90	0.34	0.34	1.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	37.27	24.85	7.45	9.94	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	26.90	20.76	3.77	8.02	0.47	0.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	15.69	13.88	1.81	5.43	0.00	0.00	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	17.29	25.94	5.60	6.61	0.00	0.00	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	17.15	12.36	1.99	4.79	0.40	0.00	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	21.21	14.31	3.45	6.41	0.00	0.00	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	14.17	22.43	0.00	4.72	0.00	1.18	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	10.50	12.84	1.75	4.67	0.58	0.00	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	35.55	18.87	3.51	7.02	1.32	0.00	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	31.36	29.67	6.78	2.54	0.85	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	14.92	8.95	5.37	2.39	1.19	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	9.70	10.19	4.85	4.85	0.00	0.97	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	11.41	6.85	5.71	1.14	0.00	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	5.82	6.24	4.57	2.08	0.83	0.00	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	7.87	5.62	4.50	0.00	1.12	2.25	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	10.47	6.98	2.85	1.27	0.32	0.00	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	3.76	5.85	4.18	0.84	0.00	1.25	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	6.96	8.01	4.53	1.28	0.81	0.46	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	7.26	5.40	4.05	0.68	0.68	1.01	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	6.60	3.87	3.19	1.37	0.23	0.23	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	6.12	7.21	3.39	1.31	0.66	0.33	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	7.52	6.45	3.22	2.36	1.29	0.43	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	6.67	7.32	3.88	1.08	0.22	1.08	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	5.48	7.35	3.24	1.62	0.62	0.12	0.50
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	7.03	6.00	2.74	0.69	1.20	0.69	0.69
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	4.49	4.16	1.92	1.60	0.32	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	10.07	6.16	2.24	1.12	0.56	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	7.36	6.49	1.30	0.87	0.43	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	7.93	7.93	2.64	2.64	0.00	0.00	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	6.00	10.23	2.82	2.82	0.35	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	5.81	5.09	2.18	3.63	0.00	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	8.04	5.77	3.15	2.10	1.40	0.00	0.35
Hepatocyte, donor1	11523-119I2	16.95	7.26	15.74	2.42	2.42	1.21	1.21
Hepatocyte, donor2	11603-120I1	7.54	16.16	9.70	1.08	1.08	4.31	0.00
Hepatocyte, donor3	11684-122I1	7.98	12.88	9.20	1.23	0.00	1.84	2.45
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	16.32	5.22	0.00	14.36	1.96	0.00	3.26
Intestinal epithelial cells (polarized), donor1	11246-116E4	19.40	16.78	10.84	4.19	1.92	0.00	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	12.21	16.19	8.51	3.02	1.65	0.27	0.82
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	9.55	9.55	0.00	3.18	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	0.00	6.68	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	27.08	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	6.92	5.54	0.00	0.00	0.00	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	5.01	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	5.13	10.25	5.13	5.13	0.00	5.13	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	13.71	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	6.50	3.25	0.00	0.00	0.00	1.62	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	3.33	0.00	3.33	1.67	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	3.63	3.63	7.26	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	7.94	1.32	2.65	3.97	1.32	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	4.43	3.33	2.22	2.22	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	7.56	2.52	3.15	1.89	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	6.19	1.55	3.09	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	14.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	7.75	7.75	1.29	1.29	0.00	0.00	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	4.83	3.22	0.00	3.22	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	6.52	7.33	4.07	2.44	0.00	1.63	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	3.78	3.36	1.68	0.84	0.00	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	8.04	8.04	0.00	2.41	0.80	0.80	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	1.85	1.85	0.92	1.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	15.08	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	3.30	4.25	1.89	0.47	0.00	0.47	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	5.44	0.91	0.00	2.72	0.91	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	9.69	3.23	1.08	2.15	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	3.81	2.54	1.27	3.81	0.00	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	1.91	5.10	0.00	1.91	0.00	1.28	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	1.82	1.82	0.00	1.82	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	5.00	2.86	2.86	1.43	0.00	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	6.64	9.95	0.00	6.64	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	41.70	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	3.70	0.93	1.23	1.23	0.00	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	3.51	0.00	1.76	5.27	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	9.43	6.29	3.14	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	2.78	9.74	4.17	2.78	0.00	0.70	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	8.85	0.00	0.00	2.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	0.00	0.00	6.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	6.10	3.49	0.00	3.49	0.00	0.87	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	4.50	2.25	0.00	2.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	3.48	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	10.67	3.20	2.13	9.60	0.00	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	9.70	0.00	1.39	8.31	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	8.55	0.00	0.00	5.70	0.00	2.85	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	7.36	1.84	0.92	2.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	9.08	0.00	3.03	6.05	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	6.21	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	8.46	4.23	1.06	3.17	1.06	1.06	0.00
Keratinocyte - epidermal, donor1	11272-116H3	12.89	17.71	11.91	2.20	1.14	0.73	0.16
Keratinocyte - epidermal, donor2	11349-117G8	2.34	4.10	2.93	1.17	0.00	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	8.52	13.06	6.15	2.56	0.95	1.33	0.09
Keratinocyte - oral, donor1	11251-116E9	10.90	18.39	13.96	2.27	1.48	0.57	0.34
Keratocytes, donor1	11527-119I6	12.03	11.69	7.22	2.06	0.69	0.00	0.00
Keratocytes, donor2	11607-120I5	8.20	2.34	1.17	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	17.78	26.48	10.67	3.95	0.59	0.20	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	6.59	10.99	8.79	0.00	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	9.71	11.87	4.31	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	13.72	24.91	7.96	3.23	1.27	0.35	1.15
Lens Epithelial Cells, donor3	11690-122I7	18.06	27.04	16.55	4.24	2.93	1.41	1.82
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	5.34	9.25	4.74	1.07	2.49	0.24	0.71
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	3.07	4.74	2.51	1.12	0.28	0.00	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	6.93	8.19	8.66	2.20	2.36	0.16	0.94
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	2.69	4.84	6.45	1.61	1.08	0.54	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	3.78	2.84	5.36	0.95	1.58	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	4.10	2.80	3.34	0.86	0.43	0.00	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	7.80	8.21	4.92	2.05	1.23	0.00	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	3.29	3.79	1.77	0.25	0.76	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	2.96	5.35	4.79	0.56	1.13	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	2.77	8.70	3.56	0.40	2.37	0.79	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	6.01	6.20	3.88	1.36	1.16	0.19	0.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	2.22	3.33	3.15	0.56	0.19	0.19	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	6.27	6.97	4.88	1.39	1.05	0.00	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	3.58	6.68	3.82	0.72	1.91	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	3.02	3.71	4.53	0.82	0.41	0.14	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	5.24	8.93	5.54	1.85	0.62	0.00	0.92
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	2.18	3.12	1.25	1.25	0.31	0.31	0.94
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	5.12	7.32	4.39	1.28	0.55	0.00	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	3.95	3.95	3.95	0.66	0.66	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	2.93	3.81	1.76	0.29	0.59	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	2.99	3.73	3.73	1.24	0.25	0.00	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	5.33	7.76	5.82	1.94	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	5.92	5.92	6.46	0.54	0.27	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	4.39	3.78	4.39	0.45	0.91	0.00	0.45
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	1.56	6.22	2.07	1.56	0.00	0.00	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	6.91	9.21	7.96	1.26	0.63	0.00	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	3.91	4.81	4.21	0.60	0.60	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	2.75	4.82	4.13	0.69	1.38	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	5.08	6.59	5.27	0.75	1.51	0.00	0.94
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	2.12	4.03	2.65	0.42	0.42	0.11	0.42
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	5.33	6.78	4.36	0.48	0.48	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	4.30	4.96	4.30	1.32	0.99	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	3.84	2.85	2.97	0.74	1.49	0.12	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	7.40	8.89	3.33	2.59	1.85	0.37	1.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	5.68	6.18	4.45	0.99	0.99	0.00	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	2.61	4.54	2.61	0.00	0.69	0.55	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	4.50	8.36	7.72	1.61	2.25	0.32	1.29
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	8.52	10.04	6.70	2.43	1.83	0.61	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	4.90	7.98	7.00	0.98	3.08	0.28	0.98
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	4.98	5.33	5.69	1.42	1.07	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	2.91	4.85	2.42	0.00	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	1.56	2.80	2.80	0.47	0.47	0.47	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	4.30	6.09	4.30	0.36	0.00	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	3.92	5.23	5.23	1.63	1.31	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	1.41	2.12	1.18	0.24	0.47	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	6.56	7.43	5.69	1.73	2.35	0.50	0.87
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	4.87	2.05	3.07	0.00	1.02	0.00	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	4.18	3.28	2.39	1.49	0.00	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	6.80	9.06	4.53	2.27	2.27	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	15.34	11.51	7.67	1.53	0.77	4.60	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	8.91	4.45	3.71	0.00	1.48	2.23	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	15.23	15.23	5.08	3.39	1.27	4.65	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	11.25	8.44	4.92	0.70	1.41	2.81	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	12.14	4.67	2.80	1.87	0.00	3.74	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	12.37	8.76	6.18	1.03	1.55	2.06	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	10.71	5.95	5.95	0.00	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	13.12	8.60	10.86	1.81	0.23	2.26	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	16.00	11.05	8.14	4.36	0.87	2.33	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	11.25	9.90	6.30	2.25	0.45	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	17.61	18.43	15.72	3.93	1.63	2.30	0.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	13.35	10.78	7.19	4.11	0.00	2.05	1.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	13.41	12.35	5.65	0.35	0.00	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	12.66	6.66	4.66	1.33	0.67	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	19.36	10.19	13.24	2.55	0.00	3.06	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	12.81	10.67	7.20	2.40	1.33	1.33	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	13.60	12.85	10.77	2.08	0.57	3.40	0.94
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	18.41	12.88	14.11	1.84	0.00	3.07	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	18.75	14.68	13.86	1.63	2.45	1.63	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	11.87	13.33	8.95	3.96	0.62	2.08	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	13.45	8.69	10.37	2.52	0.28	1.12	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	12.36	12.36	6.18	1.03	0.00	4.12	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	13.06	10.16	12.48	2.90	0.58	3.19	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	10.46	13.45	6.28	2.39	0.60	1.20	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	9.96	8.85	8.30	3.32	0.00	2.77	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	14.49	13.08	12.73	3.53	0.35	2.83	1.77
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	13.64	12.54	8.85	3.69	0.74	1.11	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	10.36	11.51	2.30	2.30	0.00	3.45	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	17.27	11.13	8.06	2.30	0.77	1.54	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	11.89	10.76	10.19	3.40	0.00	0.57	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	8.20	8.20	6.56	4.10	1.64	1.64	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	8.13	13.10	10.39	1.81	1.36	1.36	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	12.93	12.21	10.05	2.15	0.00	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	9.71	11.95	5.23	2.99	0.75	2.24	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	17.84	11.15	5.20	3.72	1.11	1.11	1.49
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	10.34	10.34	8.61	2.58	0.00	2.15	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	16.27	5.14	6.85	1.71	0.86	2.57	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	12.99	14.33	6.66	2.67	1.00	2.00	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	12.07	9.65	9.05	5.43	0.60	1.21	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	10.66	12.09	4.27	0.71	0.71	2.13	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	12.37	9.97	8.59	2.75	1.03	3.78	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	18.79	9.12	7.51	3.76	0.00	4.83	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	9.43	9.43	7.41	2.02	0.00	1.35	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	15.19	11.48	10.00	2.96	0.74	1.48	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	23.26	11.63	10.47	3.49	1.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	12.69	12.69	9.52	2.12	0.00	3.17	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	14.81	8.40	8.80	3.20	1.20	1.60	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	18.17	13.81	8.72	2.91	0.00	3.63	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	19.16	13.03	13.80	3.83	0.00	4.60	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	13.32	15.29	8.88	2.47	0.99	9.87	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	20.70	8.47	13.17	1.88	0.94	6.59	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	10.56	18.10	11.06	4.02	0.50	8.05	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	16.67	10.81	8.56	4.51	0.45	3.60	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	15.49	10.33	6.88	6.88	0.00	3.44	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	22.27	14.70	14.70	2.23	0.00	4.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	18.77	20.33	12.90	3.13	0.39	2.74	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	12.53	7.92	4.62	3.30	1.32	4.62	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	17.12	12.45	9.86	3.11	0.52	4.67	2.08
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	21.00	14.88	12.25	4.38	0.88	3.94	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	18.45	11.74	8.39	5.03	1.12	3.35	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	19.87	13.25	10.16	2.21	1.32	3.53	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	13.50	11.57	11.57	4.63	1.16	3.47	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	18.74	9.62	8.10	4.05	0.00	3.54	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	14.42	12.02	12.98	7.21	0.96	2.40	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	15.11	12.72	9.94	2.78	0.00	1.19	1.19
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	17.62	13.98	10.94	0.61	0.00	1.22	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	8.30	6.23	6.92	1.38	0.00	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	23.18	14.44	14.82	1.90	0.38	1.90	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	17.04	9.81	8.78	4.65	1.55	2.58	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	12.09	10.88	2.42	3.02	1.21	4.84	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	16.80	12.99	8.56	2.54	0.32	3.17	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	19.72	11.73	10.13	1.60	1.60	3.20	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	9.19	9.19	0.57	3.45	0.00	5.17	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	15.94	13.37	13.88	3.09	1.03	3.60	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	15.56	8.49	9.90	4.24	0.71	0.71	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	15.32	5.11	6.81	2.27	0.00	1.13	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	9.98	9.15	9.98	2.50	0.00	2.08	1.66
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	24.27	16.44	10.96	3.13	1.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	12.11	5.01	4.59	2.92	0.42	1.67	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	15.80	11.15	11.62	3.25	0.46	1.39	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	16.73	8.70	11.37	2.01	0.00	3.35	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	11.23	5.88	4.81	2.67	0.53	2.67	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	17.38	10.10	7.27	3.23	0.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	12.85	12.85	5.51	0.92	0.00	5.51	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	15.11	7.11	0.00	5.33	0.00	2.67	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	13.68	13.11	11.40	3.99	0.57	2.28	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	18.41	6.90	5.37	3.07	0.77	3.83	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	16.42	6.57	1.64	2.19	0.00	0.55	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	16.93	15.59	14.70	3.12	0.00	0.00	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	16.64	15.86	14.04	2.34	1.04	1.82	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	12.60	5.97	1.99	2.65	0.00	1.99	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	20.79	10.39	4.16	2.08	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	7.98	8.89	16.18	0.91	0.46	0.00	0.91
Macrophage - monocyte derived, donor2	11313-117C8	5.32	8.99	15.60	0.92	0.92	0.18	0.73
Macrophage - monocyte derived, donor3	11389-118C3	7.60	10.22	17.96	0.66	0.79	0.26	0.52
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	6.90	9.56	4.78	2.12	1.59	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	9.98	17.59	10.62	0.79	2.38	1.43	0.79
Mallassez-derived cells, donor3	11930-125I4	9.45	13.34	5.98	2.78	2.08	0.97	0.14
Mammary Epithelial Cell, donor1	11273-116H4	11.46	22.82	18.73	1.40	1.89	1.00	0.50
Mammary Epithelial Cell, donor2	11350-117G9	11.29	19.40	9.27	1.16	2.61	1.74	1.16
Mammary Epithelial Cell, donor3	11422-118F9	4.99	5.24	6.98	1.50	0.50	0.00	0.25
Mast cell - stimulated, donor1	11487-119E2	11.52	53.56	94.91	2.03	67.12	0.00	67.79
Mast cell, donor1	11563-120D6	10.38	16.87	20.01	3.89	0.54	0.87	0.65
Mast cell, donor2	11565-120D8	34.18	30.01	49.33	6.54	1.78	1.78	2.08
Mast cell, donor3	11566-120D9	45.48	41.65	64.61	11.93	2.48	0.90	1.58
Mast cell, donor4	11567-120E1	33.86	37.41	54.78	7.98	1.24	2.48	2.13
Mast cell, expanded and stimulated, donor5	11940-126A5	9.54	9.76	16.97	3.33	1.11	0.78	1.00
Mast cell, expanded and stimulated, donor8	11942-126A7	9.92	7.59	17.51	5.25	1.75	0.00	1.17
Mast cell, expanded, donor5	11939-126A4	13.08	9.64	10.90	3.44	1.38	0.11	0.69
Mast cell, expanded, donor8	11941-126A6	17.24	17.07	14.23	5.19	1.17	0.00	1.17
Melanocyte - dark, donor1	11502-119F8	4.28	4.97	2.09	1.09	0.60	0.20	0.50
Melanocyte - dark, donor2	11582-120F7	10.38	9.34	5.19	4.15	0.69	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	12.31	17.31	13.69	2.10	0.72	0.07	0.65
Melanocyte - light, donor1	11274-116H5	12.46	18.81	10.58	0.71	0.24	0.00	0.00
Melanocyte - light, donor2	11351-117H1	5.46	15.01	6.14	3.41	0.00	0.68	0.00
Melanocyte - light, donor3	11423-118G1	5.20	8.67	2.60	1.73	0.00	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	11.14	14.99	5.10	2.50	1.04	0.00	0.62
Melanocyte, donor2 (MC+2)	12739-135I3	8.61	15.06	8.34	2.42	1.34	0.27	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	18.75	24.11	8.57	2.95	1.34	1.07	1.34
Meningeal Cells, donor1	11493-119E8	13.03	12.41	2.98	3.60	1.24	0.62	0.50
Meningeal Cells, donor2	11573-120E7	11.44	7.92	1.32	6.16	0.00	0.00	1.76
Meningeal Cells, donor3	11654-122E7	13.53	12.06	8.64	3.99	3.59	0.49	1.96
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	10.55	12.55	7.70	2.57	1.14	0.29	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	13.28	18.52	15.40	3.42	1.91	0.70	0.81
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	2.63	3.94	2.63	2.63	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	3.92	2.62	2.62	2.62	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	8.61	9.33	5.02	2.15	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	9.53	14.40	6.99	2.75	1.06	0.85	1.27
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	9.05	10.56	6.03	0.50	1.51	0.00	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	7.03	6.81	3.74	2.42	0.66	0.22	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	4.38	4.38	2.92	1.46	0.00	1.46	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	6.34	7.16	3.89	0.61	0.41	0.00	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	9.14	12.33	1.52	2.91	0.28	0.42	0.97
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	3.35	5.20	4.83	1.12	0.37	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	12.63	19.87	15.66	3.95	1.32	0.26	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	2.67	7.72	2.08	1.48	0.89	0.00	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	2.34	0.00	0.00	0.00	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	4.48	5.76	3.84	1.28	1.28	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	6.73	6.73	7.80	1.42	1.06	0.71	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	7.19	11.26	13.45	1.56	0.94	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	3.63	4.35	3.63	0.00	0.73	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	13.79	24.93	12.20	2.39	3.18	2.65	0.80
Mesothelial Cells, donor2	12156-128G5	15.51	13.01	12.01	0.50	2.00	1.50	0.50
Mesothelial Cells, donor3	11402-118D7	19.37	21.90	11.27	2.38	1.73	2.10	1.23
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	16.20	13.50	31.06	1.35	1.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	5.17	7.14	15.52	1.23	0.25	0.74	1.23
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	8.83	12.07	18.85	0.59	0.59	0.29	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	6.91	20.74	20.74	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	3.72	4.65	9.92	0.31	1.24	0.00	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	4.77	8.30	15.97	1.24	0.62	0.00	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	6.95	6.95	34.74	0.00	0.00	0.00	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	6.51	9.51	16.52	0.50	0.50	0.00	1.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	9.78	13.50	21.88	0.47	2.79	0.47	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	7.32	9.75	12.80	1.22	0.61	0.20	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	7.52	10.69	17.03	1.58	1.19	1.19	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	8.55	17.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	5.31	8.85	7.08	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	10.64	6.08	15.96	0.76	0.76	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	14.47	10.53	28.95	1.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	10.40	14.64	14.22	0.85	0.64	0.00	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	13.81	12.89	14.73	0.92	0.00	0.92	1.84
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	16.99	17.59	16.99	2.68	0.30	0.00	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	11.74	16.77	23.47	3.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	33.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	14.05	16.81	16.81	2.26	0.00	0.00	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	10.93	12.83	18.06	1.66	0.24	1.19	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	24.88	29.30	32.62	1.11	1.11	0.00	1.66
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	18.42	25.10	19.80	2.30	0.69	0.92	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	12.62	16.20	20.82	2.31	0.63	0.84	1.26
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	23.64	30.57	30.17	2.04	1.02	0.82	0.61
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	13.52	19.31	16.30	1.50	0.86	0.21	1.07
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	15.56	22.23	21.56	1.11	1.56	0.22	1.33
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	41.27	20.64	10.32	10.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	16.86	26.72	19.27	0.66	0.88	0.00	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	16.22	24.33	21.29	1.01	0.00	0.51	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	16.57	26.51	21.54	1.66	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	23.92	29.63	23.92	1.90	1.09	0.27	1.36
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	13.53	18.82	19.41	0.59	0.88	0.59	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	16.35	10.90	11.99	4.36	0.00	1.09	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	7.69	5.77	11.05	1.92	1.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	13.61	15.21	24.01	0.80	1.60	0.00	2.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	12.34	16.45	15.08	0.00	2.74	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	9.01	7.51	10.51	1.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	20.39	10.19	2.04	2.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	7.44	7.88	8.32	1.75	0.44	0.00	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	11.04	14.35	12.14	0.00	0.00	0.00	2.21
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	12.17	12.17	14.09	0.00	1.28	1.28	1.28
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	6.94	8.68	6.94	0.50	0.50	0.25	0.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	8.35	11.83	4.87	0.00	0.00	0.70	1.39
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	4.42	15.47	8.84	0.00	2.21	0.00	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	5.81	6.84	8.89	0.68	0.00	0.00	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	7.88	10.07	10.94	0.88	1.75	0.88	1.75
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	8.17	12.78	12.07	1.42	0.71	0.36	1.07
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	6.45	9.26	7.57	0.84	0.56	0.00	0.84
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	3.74	9.14	7.07	1.25	2.91	0.42	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	6.41	11.65	15.73	1.17	1.75	0.58	1.75
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	8.75	7.84	11.16	1.51	1.51	1.21	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	10.85	9.18	14.19	2.92	0.42	0.00	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	28.88	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	10.16	9.24	11.08	0.00	0.92	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	6.26	13.66	9.11	1.14	0.57	0.00	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	11.05	16.17	15.48	0.83	1.52	0.28	0.55
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	5.18	9.07	5.70	0.52	1.81	0.26	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	10.72	10.30	7.29	0.43	1.72	0.00	2.57
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	13.34	19.06	13.97	0.64	0.64	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	8.81	10.68	9.87	0.80	0.27	0.53	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	15.27	13.47	11.67	1.80	1.20	0.90	0.90
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	7.91	16.39	14.13	1.27	0.85	0.57	1.27
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	7.01	9.56	6.05	0.32	0.64	0.32	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	7.96	9.73	10.39	1.33	0.22	0.00	1.55
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	12.89	13.65	15.55	0.38	1.52	0.38	2.28
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	5.68	11.08	8.24	1.42	0.00	0.85	1.42
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	10.08	8.36	7.62	2.46	0.25	0.25	0.98
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	6.52	11.73	16.94	1.30	1.30	1.30	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	7.06	14.11	6.47	1.18	0.88	0.59	0.88
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	11.24	14.70	9.23	0.86	1.44	0.29	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	12.36	16.90	15.25	1.65	2.47	0.82	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	9.83	10.72	11.02	1.19	1.79	0.30	1.19
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	0.00	7.53	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	0.00	3.56	3.56	1.78	0.00	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	3.94	3.94	8.21	0.00	0.66	0.33	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	4.21	5.26	8.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	4.74	6.52	12.26	0.59	0.59	0.40	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	6.52	8.38	8.38	1.86	0.00	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	5.26	5.63	5.63	1.50	0.38	0.00	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	1.33	5.59	6.92	0.00	0.00	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	3.85	4.98	7.01	0.34	0.45	0.00	0.45
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	2.21	6.63	2.95	0.74	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	3.66	6.96	9.89	0.00	0.37	0.00	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	9.33	10.89	9.33	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	5.88	8.55	6.41	1.60	0.00	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	3.86	3.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	3.03	5.05	3.03	2.02	0.00	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	5.06	6.32	8.43	2.53	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	13.62	29.96	42.22	0.00	5.45	0.00	8.17
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	12.72	20.35	26.70	0.00	1.27	0.00	1.27
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	8.91	12.96	22.68	0.00	0.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	12.08	10.57	22.66	3.02	0.00	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	85.65	74.23	291.22	0.00	102.78	22.84	17.13
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	42.41	78.30	179.43	3.26	29.36	0.00	13.05
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	28.51	23.76	47.52	0.00	9.50	0.00	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	50.20	100.39	0.00	25.10	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	12.50	20.04	7.54	3.23	1.51	0.65	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	10.97	15.16	5.75	2.61	0.00	2.09	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	22.69	22.69	10.01	2.67	1.33	1.33	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	16.28	20.45	10.43	3.76	1.67	2.09	1.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	11.60	9.70	5.51	1.14	2.85	0.95	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	23.94	33.51	4.79	9.58	3.19	1.60	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	18.36	14.28	8.84	2.04	3.40	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	14.70	11.03	14.70	3.68	1.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	19.25	18.83	4.19	3.35	2.51	1.67	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	15.57	14.41	5.11	1.86	1.39	0.70	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	25.94	31.89	6.22	2.97	0.27	0.81	1.35
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	27.75	25.23	6.31	5.68	1.05	1.26	0.84
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	44.54	11.13	0.00	0.00	0.00	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	16.88	27.80	7.94	1.99	0.50	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	11.10	11.10	2.17	2.98	0.54	0.81	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	16.32	17.68	5.21	4.08	0.91	1.36	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	23.35	27.76	7.84	4.57	0.65	1.31	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	17.86	20.59	6.20	3.65	1.09	0.73	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	30.23	25.46	6.37	5.83	0.53	0.53	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	24.61	21.01	6.60	6.00	1.20	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	9.85	9.19	3.28	4.59	2.63	1.31	1.64
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	17.56	20.33	4.72	5.69	0.81	0.65	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	32.28	34.04	9.17	7.41	1.06	0.18	1.06
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	14.77	15.47	7.74	5.63	0.70	1.41	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	19.31	16.09	4.14	6.90	0.46	1.38	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	28.92	27.64	6.43	9.32	0.00	0.96	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	11.38	11.04	5.52	2.76	1.38	1.72	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	35.40	40.46	35.40	0.00	2.53	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	26.96	28.52	10.25	6.24	1.78	0.89	1.11
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	19.05	15.24	3.39	3.39	0.42	0.85	1.27
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	17.09	10.44	5.93	4.03	0.47	0.71	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	23.18	24.90	7.30	6.87	0.86	1.29	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	18.06	18.06	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	21.66	31.99	8.00	5.66	0.33	1.33	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	29.76	26.60	7.21	4.51	0.45	1.35	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	19.44	17.46	5.95	1.19	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	18.57	13.93	5.57	2.79	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	17.78	12.86	4.54	4.16	0.38	1.14	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	22.16	23.79	5.54	4.89	0.33	0.33	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	28.76	26.58	7.41	9.15	0.44	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	25.33	26.23	10.40	6.33	0.45	0.45	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	12.35	34.39	4.41	6.17	0.88	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	20.61	20.61	8.64	5.98	0.66	1.33	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	34.23	29.27	7.44	11.41	0.00	0.00	1.49
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	16.08	26.41	6.13	4.98	0.38	0.77	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	16.03	15.12	7.86	2.12	0.30	0.30	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	29.18	25.64	8.62	3.98	0.44	0.88	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	20.33	23.72	17.62	3.39	0.00	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	45.99	30.66	5.11	10.22	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	21.34	23.78	6.71	9.15	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	19.51	19.83	6.92	4.72	0.63	1.26	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	19.98	19.37	5.45	5.15	0.00	1.21	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	26.90	30.06	12.66	2.37	0.79	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	21.54	24.94	10.20	4.53	1.13	1.13	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	5.06	15.17	5.06	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	9.19	18.01	12.67	1.49	1.37	1.49	0.37
Myoblast, donor2	11322-117D8	14.00	15.53	14.77	4.03	1.15	0.58	0.58
Myoblast, donor3	11398-118D3	14.63	21.19	15.47	3.36	2.35	0.67	1.35
NK T cell leukemia cell line:KHYG-1	10777-110G3	9.92	6.57	4.52	1.90	0.44	0.29	0.15
Natural Killer Cells, donor1	11230-116C6	33.83	30.75	32.60	17.84	4.31	5.23	2.77
Natural Killer Cells, donor2	11311-117C6	37.09	28.35	28.65	19.60	3.02	4.52	1.51
Natural Killer Cells, donor3	11387-118C1	40.12	35.71	37.36	15.83	2.39	4.60	2.02
Neural stem cells, donor1	11275-116H6	58.07	61.34	36.66	13.79	3.27	2.18	2.90
Neural stem cells, donor2	11352-117H2	96.28	55.84	19.26	34.66	0.00	0.00	0.00
Neurons, donor1	11494-119E9	42.10	25.03	3.41	13.65	0.00	0.00	1.14
Neurons, donor2	11574-120E8	40.51	25.98	3.30	19.59	0.22	0.44	2.64
Neurons, donor3	11655-122E8	47.69	23.84	9.04	9.87	0.00	0.00	1.64
Neutrophils, donor1	11233-116C9	26.91	39.90	104.86	3.71	3.71	0.93	0.93
Neutrophils, donor2	11314-117C9	17.39	40.58	46.38	2.90	0.00	2.90	2.90
Neutrophils, donor3	11390-118C4	53.75	65.36	122.78	5.50	4.89	4.28	1.83
Nucleus Pulposus Cell, donor1	11252-116F1	20.19	17.34	8.19	5.70	1.07	0.47	1.31
Nucleus Pulposus Cell, donor2	11409-118E5	9.12	9.77	2.60	3.26	0.33	0.00	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	12.03	10.03	1.40	4.61	0.40	0.20	1.00
Olfactory epithelial cells, donor1	11933-125I7	9.64	13.08	7.57	2.06	0.14	0.55	0.28
Olfactory epithelial cells, donor2	11934-125I8	12.88	15.20	8.83	3.04	0.58	1.16	0.14
Olfactory epithelial cells, donor3	11935-125I9	10.22	12.03	6.36	1.70	1.14	0.68	0.57
Olfactory epithelial cells, donor4	11936-126A1	17.82	18.31	7.79	3.31	0.29	0.78	0.49
Oligodendrocyte - precursors, donor1	11496-119F2	16.25	25.28	11.43	1.20	3.01	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	6.81	11.49	7.02	1.28	0.85	0.64	0.00
Osteoblast - differentiated, donor2	11353-117H3	2.29	5.72	3.43	2.29	0.00	3.43	0.00
Osteoblast - differentiated, donor3	11425-118G3	6.21	8.07	0.62	2.48	0.00	1.24	0.00
Osteoblast, donor1	11277-116H8	4.69	3.91	2.93	0.98	0.59	0.00	0.39
Osteoblast, donor2	11354-117H4	17.56	21.07	11.94	4.21	2.11	0.00	0.70
Osteoblast, donor3	11426-118G4	16.88	22.75	14.04	4.44	1.78	0.71	0.53
Pancreatic stromal cells, donor1	11249-116E7	9.69	14.74	10.78	3.12	1.94	1.01	0.93
Pericytes, donor1	11491-119E6	4.01	4.45	0.45	1.22	0.33	0.11	0.11
Pericytes, donor2	11571-120E5	5.66	2.94	1.81	1.81	0.00	0.23	0.00
Pericytes, donor3	11652-122E5	5.09	8.14	2.64	1.42	1.22	0.20	0.20
Perineurial Cells, donor1	11499-119F5	11.42	17.63	7.01	2.37	1.02	0.34	0.90
Perineurial Cells, donor2	11579-120F4	11.59	16.75	11.41	1.56	2.21	0.28	0.83
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	46.85	33.47	40.48	29.64	6.06	2.23	1.59
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	26.20	21.06	28.16	15.18	2.69	2.45	1.22
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	35.20	27.95	34.17	16.31	3.36	3.88	1.81
Placental Epithelial Cells, donor1	11278-116H9	7.89	4.78	3.83	1.67	0.24	0.24	0.48
Placental Epithelial Cells, donor2	11355-117H5	12.20	6.65	2.22	0.00	2.22	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	4.12	4.71	2.36	0.39	0.20	0.59	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	8.54	6.65	3.16	0.95	0.32	0.63	0.32
Preadipocyte - breast, donor1	11467-119B9	14.82	13.88	9.57	2.81	0.94	1.88	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	18.01	27.15	17.10	3.79	1.70	1.04	0.52
Preadipocyte - breast, donor2	11328-117E5	10.36	12.38	7.43	1.80	0.00	0.68	1.35
Preadipocyte - omental, donor1	11468-119C1	14.71	20.46	10.87	2.98	1.49	1.81	0.53
Preadipocyte - omental, donor2	11329-117E6	14.40	22.26	8.73	3.93	0.44	0.44	0.44
Preadipocyte - omental, donor3	11403-118D8	17.05	19.34	9.31	1.86	2.15	1.72	0.72
Preadipocyte - perirenal, donor1	11469-119C2	2.95	5.91	0.98	0.98	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	5.53	8.60	8.60	3.07	0.61	1.54	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	14.52	12.40	10.27	3.36	2.12	0.18	1.24
Preadipocyte - subcutaneous, donor3	11428-118G6	6.81	10.73	8.34	1.70	0.68	1.19	0.68
Preadipocyte - visceral, donor1	11280-116I2	16.02	16.49	15.18	3.63	2.70	1.30	1.96
Preadipocyte - visceral, donor2	11357-117H7	22.09	17.03	13.81	4.14	5.06	1.84	0.46
Preadipocyte - visceral, donor3	11429-118G7	9.30	8.36	4.08	1.67	0.73	0.84	0.42
Prostate Epithelial Cells (polarized), donor1	11253-116F2	20.06	15.69	10.56	4.83	0.75	0.60	0.91
Prostate Epithelial Cells, donor2	11331-117E8	12.46	19.77	8.94	2.03	1.35	1.22	0.41
Prostate Epithelial Cells, donor3	11404-118D9	13.10	22.05	8.88	2.27	0.49	0.43	0.18
Prostate Stromal Cells, donor1	11254-116F3	8.31	9.11	7.29	1.94	0.91	0.68	0.34
Prostate Stromal Cells, donor2	11332-117E9	12.19	11.30	6.99	1.97	0.54	0.90	0.36
Prostate Stromal Cells, donor3	11405-118E1	8.45	11.89	8.55	2.82	1.04	1.36	0.42
Renal Cortical Epithelial Cells, donor1	11516-119H4	5.47	4.74	1.09	2.92	0.73	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	13.79	20.45	8.73	2.08	0.90	0.62	0.55
Renal Epithelial Cells, donor1	11517-119H5	5.07	9.13	2.54	1.01	0.51	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	2.85	4.98	0.71	2.13	1.42	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	15.14	21.81	7.62	2.22	1.91	0.21	0.95
Renal Glomerular Endothelial Cells, donor1	11514-119H2	2.72	2.72	2.04	0.68	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	3.50	2.70	2.02	0.54	0.13	0.13	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	11.10	9.32	7.10	3.11	2.44	0.00	1.55
Renal Glomerular Endothelial Cells, donor4	11783-124B1	2.00	6.65	0.67	0.67	0.67	0.00	1.33
Renal Mesangial Cells, donor1	11518-119H6	7.70	7.04	1.76	0.88	1.10	0.22	0.66
Renal Mesangial Cells, donor2	11598-120H5	3.76	7.52	3.76	3.13	0.63	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	4.99	6.94	2.22	0.28	0.55	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	5.37	7.78	4.03	1.61	0.81	0.54	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	4.64	5.90	5.48	0.42	0.00	0.00	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	5.59	6.36	4.63	1.35	0.19	0.19	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	6.22	13.74	6.74	2.33	0.78	0.26	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	9.10	8.24	3.41	1.99	1.14	0.28	1.14
Retinal Pigment Epithelial Cells, donor2	11608-120I6	2.06	3.09	1.03	2.06	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	14.05	14.30	7.03	3.76	1.00	0.75	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	18.71	20.71	20.31	3.88	1.74	0.67	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	19.65	18.76	8.04	2.68	1.79	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	12.66	14.86	5.50	3.85	0.00	0.00	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	26.68	24.94	13.92	2.90	0.58	0.00	1.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	24.96	18.33	3.77	3.77	0.52	0.65	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	18.67	21.75	7.45	4.57	0.79	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	23.53	25.77	10.15	4.24	1.23	0.56	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	18.85	14.02	6.82	5.09	0.62	0.87	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	21.91	20.51	7.11	3.26	0.70	0.58	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	29.82	29.12	7.63	5.08	1.85	0.00	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	21.77	16.02	5.75	4.24	0.14	0.68	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	23.60	17.70	8.02	4.69	1.51	0.61	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	23.65	26.34	9.68	3.05	1.08	0.18	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	17.65	14.92	2.44	2.30	0.29	1.00	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	20.60	21.14	6.76	2.90	0.86	0.11	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	24.12	21.46	9.07	3.10	0.89	0.44	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	18.54	16.25	3.44	3.06	0.19	0.57	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	21.80	25.71	8.29	4.01	0.65	0.37	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	30.44	28.19	11.65	5.26	1.32	0.38	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	20.04	17.92	3.98	4.38	0.00	0.80	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	27.45	28.62	11.39	3.80	1.17	0.58	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	27.31	27.31	10.69	3.06	1.15	0.95	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	18.58	14.84	3.74	4.16	0.53	0.32	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	22.99	22.42	7.29	3.08	0.56	0.00	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	23.58	21.02	9.23	3.42	0.68	0.34	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	22.06	10.39	3.65	3.28	0.36	0.36	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	20.97	22.56	8.95	3.80	0.25	0.86	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	18.67	22.03	8.33	4.16	0.54	0.54	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	17.69	11.09	2.83	4.01	0.24	0.94	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	21.03	23.41	9.13	4.17	0.79	0.60	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	25.26	21.98	7.02	5.14	1.64	0.70	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	15.14	10.58	2.90	3.73	0.21	0.83	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	25.00	25.66	11.28	4.42	1.33	0.66	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	25.48	19.01	9.40	3.34	0.63	0.84	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	21.80	14.13	2.69	3.36	0.40	1.08	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	24.35	23.16	10.73	4.60	1.19	1.19	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	24.29	23.14	10.80	3.86	1.35	0.96	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	22.18	15.30	2.92	2.92	0.34	0.34	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	25.24	23.04	12.07	3.29	1.37	0.14	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	23.80	22.66	10.67	4.60	1.15	0.16	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	20.79	17.55	3.58	3.58	1.19	0.34	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	22.79	24.12	8.58	2.66	1.04	0.15	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	22.12	22.66	8.53	4.00	1.07	1.33	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	29.17	22.40	4.70	4.98	0.41	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	17.38	26.43	7.14	2.38	0.71	0.48	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	44.54	37.89	14.11	7.66	1.01	0.20	1.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	22.70	14.31	3.86	2.26	0.28	0.47	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	32.84	35.63	14.67	5.59	0.00	0.35	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	31.13	29.92	11.18	8.46	1.81	0.91	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	19.34	13.83	5.14	2.94	0.73	0.37	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	57.93	71.18	27.65	10.19	1.16	1.31	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	26.16	29.20	4.26	6.69	1.22	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	17.18	13.56	3.62	4.52	0.00	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	24.88	31.89	13.35	2.71	0.00	0.00	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	26.96	35.35	11.98	3.59	0.60	0.60	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	17.59	14.64	4.25	3.54	0.35	0.12	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	17.93	25.40	15.58	2.99	0.43	0.43	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	23.44	30.05	12.62	2.40	0.60	1.20	0.60
Schwann Cells, donor1	11498-119F4	3.76	4.70	2.26	1.13	0.75	0.19	0.00
Schwann Cells, donor2	11578-120F3	6.80	10.21	3.40	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	11.17	10.08	5.04	2.63	1.10	0.66	0.88
Sebocyte, donor1	11220-116B5	7.12	19.72	10.96	1.64	2.19	0.55	0.00
Sebocyte, donor2	11301-117B5	10.57	10.11	10.11	2.76	0.92	0.92	0.46
Sebocyte, donor3	11378-118B1	7.21	10.31	4.95	1.86	1.03	0.82	0.00
Sertoli Cells, donor1	11255-116F4	11.60	21.54	9.94	1.66	3.31	0.00	0.00
Sertoli Cells, donor2	11333-117F1	11.30	16.95	5.65	2.82	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	13.99	18.39	6.77	4.84	0.97	1.23	0.53
Skeletal Muscle Cells, donor2	11358-117H8	7.23	6.51	2.17	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	5.02	7.52	2.51	1.67	1.67	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	9.74	8.64	4.08	2.83	0.63	0.47	0.79
Skeletal Muscle Cells, donor5	11455-119A6	10.41	9.66	4.01	2.68	1.49	0.30	0.30
Skeletal Muscle Cells, donor6	11459-119B1	12.31	12.00	4.16	2.77	0.77	0.00	0.92
Skeletal Muscle Satellite Cells, donor1	11240-116D7	15.37	17.01	9.07	4.79	2.90	0.25	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	14.41	13.98	8.42	5.14	1.71	0.14	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	14.88	19.94	11.01	4.96	1.69	0.79	0.60
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	17.44	19.63	8.59	4.89	0.34	0.67	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	12.30	7.24	2.17	2.17	0.00	1.45	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	6.05	5.78	3.03	1.79	0.28	0.41	0.28
Skin - palm, donor1	10286-104F7	18.80	18.80	34.92	5.37	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	10.96	12.25	8.65	1.15	0.86	0.43	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	39.26	25.35	15.54	9.81	4.09	3.27	5.73
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	8.57	12.33	5.58	1.04	0.78	0.52	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	12.37	16.12	15.29	1.53	1.39	1.11	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	15.89	20.11	16.60	1.69	0.70	1.13	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	46.52	64.49	60.26	6.34	6.13	0.21	1.27
Small Airway Epithelial Cells, donor3	11406-118E2	18.21	33.05	22.34	2.40	0.45	1.50	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	7.41	10.80	3.39	1.85	0.62	0.31	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	20.23	25.35	8.89	3.56	0.89	2.45	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	9.41	12.93	11.76	1.18	1.18	1.18	1.76
Smooth Muscle Cells - Aortic, donor1	11283-116I5	7.51	8.62	3.54	1.10	1.55	2.43	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	7.48	4.33	6.69	0.00	1.58	0.39	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	10.82	14.68	13.91	3.09	0.00	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	19.01	13.01	11.01	0.00	1.00	2.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	7.59	12.24	6.65	1.20	0.93	1.06	0.40
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	8.87	9.09	4.88	1.55	0.66	0.89	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	12.42	14.60	8.45	2.05	2.18	0.90	0.90
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	14.00	16.61	10.42	1.95	2.93	0.33	1.30
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	16.54	20.67	7.09	3.54	3.25	1.18	1.77
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	9.97	21.07	10.96	2.85	2.28	0.57	0.57
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	2.44	4.39	1.14	0.81	0.49	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	16.44	13.40	4.87	5.78	0.30	1.22	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	6.57	11.87	5.56	1.01	0.76	1.01	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	12.24	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	4.77	5.72	0.95	0.48	0.48	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	10.47	14.89	10.62	3.24	1.62	0.15	0.74
Smooth Muscle Cells - Colonic, donor2	11320-117D6	12.48	12.48	5.60	2.15	0.65	0.00	0.86
Smooth Muscle Cells - Colonic, donor3	11396-118D1	10.29	13.33	10.08	2.31	1.47	0.31	0.73
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	5.57	8.66	7.73	0.77	0.93	0.77	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	4.31	5.39	2.16	0.00	1.08	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	7.47	7.77	2.69	1.49	0.90	0.30	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	3.41	3.76	1.37	1.37	0.34	0.34	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	14.21	17.04	8.95	3.14	1.65	0.16	0.71
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	20.23	24.76	11.37	5.64	1.31	3.72	0.81
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	21.39	21.62	11.15	2.05	0.68	1.14	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	3.62	4.83	0.60	1.21	0.00	1.81	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	10.07	10.07	9.01	2.65	1.06	0.53	1.85
Smooth Muscle Cells - Prostate, donor1	11257-116F6	10.65	11.58	3.33	3.33	1.20	0.93	0.53
Smooth Muscle Cells - Prostate, donor2	11335-117F3	13.40	12.77	8.01	3.38	1.13	0.88	0.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	7.61	7.10	6.34	0.51	0.51	1.01	1.27
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	12.66	20.20	8.90	1.81	1.81	0.75	0.90
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	7.50	11.25	5.25	2.25	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	2.58	9.05	3.88	1.29	3.88	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	8.37	17.21	11.16	1.40	0.93	0.47	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	10.60	7.57	4.54	1.01	0.50	1.51	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	12.85	12.85	3.76	1.25	0.31	1.25	0.94
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	3.83	4.13	0.88	0.88	0.29	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	10.33	11.83	9.25	3.08	1.92	0.75	0.92
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	18.69	9.34	5.14	5.61	0.47	0.93	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	4.61	8.20	8.49	0.58	0.29	0.43	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	5.86	7.65	6.63	1.02	0.76	0.51	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	4.14	3.95	0.56	0.75	0.38	0.56	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	10.76	12.86	7.27	2.52	1.82	0.00	1.12
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	8.38	15.75	6.12	2.01	0.92	0.34	0.34
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	2.38	2.38	1.90	0.95	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	3.67	11.01	8.07	0.98	0.49	0.98	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	14.36	13.70	4.64	2.43	0.22	1.33	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	3.80	7.90	6.14	0.29	0.88	0.29	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	17.10	17.10	5.44	2.14	0.97	0.97	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	10.58	12.43	8.99	1.06	0.79	0.26	1.06
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	5.21	6.32	4.84	1.49	0.37	0.00	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	14.73	15.81	5.03	2.52	0.72	0.72	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	11.07	13.06	8.23	2.84	0.85	1.70	1.14
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	7.09	7.48	2.36	1.58	0.00	0.00	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	8.13	11.17	5.08	1.52	0.76	0.76	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	13.98	19.17	2.80	3.19	0.00	0.80	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	12.54	11.29	6.27	2.09	0.42	1.25	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	9.63	9.17	5.50	5.04	0.46	1.38	0.00
Synoviocyte, donor1	11291-117A4	22.55	27.60	21.71	1.18	0.84	0.67	0.67
Synoviocyte, donor2	11368-117I9	7.38	11.23	6.03	2.18	0.17	1.01	0.17
Synoviocyte, donor3	11440-118H9	9.16	9.16	3.13	3.35	0.00	1.34	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	6.79	6.43	1.43	2.50	0.36	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	3.96	5.95	0.00	1.98	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	7.41	8.80	3.01	1.62	0.93	0.00	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	5.09	9.68	5.73	1.00	0.72	0.50	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	2.32	6.57	5.41	0.00	0.39	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	2.86	4.58	0.57	1.15	0.00	1.72	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	18.82	21.04	21.78	3.08	1.23	0.98	0.37
Urethra, donor2	10319-105A4	28.77	21.58	26.98	7.19	1.80	1.80	3.60
Urothelial Cells, donor1	11520-119H8	2.66	7.17	1.59	0.53	0.80	0.00	0.00
Urothelial Cells, donor2	11600-120H7	1.60	3.61	2.40	0.80	0.00	0.40	0.00
Urothelial Cells, donor3	11681-122H7	2.52	4.58	3.21	0.00	0.23	0.69	0.00
Urothelial cells, donor0	11216-116B1	5.80	20.28	15.16	0.89	0.89	0.45	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	14.24	11.57	5.34	3.56	0.89	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	28.59	10.01	7.15	4.29	0.00	0.00	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	21.22	9.58	7.53	4.79	2.74	1.37	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	23.07	7.92	9.99	8.26	1.38	1.38	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	19.75	15.11	9.30	8.13	2.91	1.16	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	9.37	6.25	6.25	6.25	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	21.11	10.10	5.51	6.42	0.00	1.84	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	21.91	8.22	14.61	3.65	0.91	2.74	0.00
Wilms' tumor cell line:G-401	10809-111A8	15.17	12.34	9.50	3.45	3.95	0.00	1.23
Wilms' tumor cell line:HFWT	10597-108E3	20.24	18.48	4.40	9.68	1.76	0.00	2.64
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	10.61	15.64	7.82	3.35	0.56	1.40	0.00
achilles tendon, donor2	10292-104G4	10.33	16.53	16.53	4.13	0.00	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	6.88	3.82	3.57	0.76	1.27	0.00	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	6.73	4.18	2.55	3.25	2.09	0.00	1.16
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	21.72	12.58	7.36	6.89	1.07	0.24	0.71
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	12.52	4.08	2.18	13.88	1.63	0.00	1.90
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	4.22	1.69	0.84	2.81	0.00	0.00	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	5.08	3.17	3.60	2.33	0.42	0.21	1.06
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	9.26	5.72	4.63	2.72	0.27	0.27	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	11.90	7.49	3.97	4.41	0.88	0.00	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	10.62	7.76	6.53	3.27	1.63	0.00	2.86
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	11.65	7.77	5.44	10.10	1.94	0.00	1.55
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	2.58	1.84	0.18	1.84	0.37	0.18	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	19.50	7.80	0.00	11.70	0.00	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	10.69	8.13	2.32	4.42	1.86	0.00	2.79
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	12.43	6.21	2.85	4.40	1.04	0.00	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	8.48	4.09	2.34	1.46	0.88	0.00	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	5.58	6.51	2.79	2.32	0.46	0.46	1.39
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	7.81	8.23	6.17	2.88	0.82	0.00	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	13.51	6.14	2.76	2.15	0.31	0.31	0.92
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	11.09	8.11	6.40	5.97	1.28	0.43	1.28
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	12.44	13.65	7.89	3.03	2.12	0.30	1.21
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	15.89	11.55	11.31	5.54	2.41	0.00	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	2.45	1.11	0.89	1.11	0.45	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	20.01	13.68	6.00	3.34	1.67	0.67	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	18.58	9.29	1.86	5.57	1.86	0.00	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	9.04	4.14	1.88	3.01	0.75	0.00	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	21.81	11.78	7.85	5.67	2.62	0.00	1.31
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	15.00	9.37	5.62	1.87	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	9.18	17.90	12.95	0.71	3.06	0.24	0.24
adipose tissue, adult, pool1	10010-101C1	20.48	20.32	20.63	3.72	2.48	1.40	0.16
adipose, donor1	10184-103D4	11.14	14.66	9.97	1.17	4.10	0.00	5.86
adipose, donor2	10185-103D5	45.01	41.36	6.08	15.41	0.00	0.00	2.03
adipose, donor3	10186-103D6	22.06	14.16	3.00	7.62	1.36	0.00	1.36
adipose, donor4	10187-103D7	13.00	14.73	2.60	5.20	1.73	0.00	3.47
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	17.52	18.31	5.52	8.84	3.31	0.79	3.95
adrenal gland, adult, pool1	10081-102A9	36.38	32.74	10.91	3.64	0.00	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	4.54	5.47	7.34	0.93	0.67	0.00	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	23.22	14.65	11.43	4.64	2.86	0.71	2.14
amniotic membrane cells, donor1	12235-129G3	14.37	16.69	19.24	1.62	1.16	1.62	0.93
amniotic membrane cells, donor2	12236-129G4	12.17	14.88	8.79	2.37	1.69	1.01	1.35
amniotic membrane cells, donor3	12237-129G5	19.44	10.90	9.13	4.42	0.29	4.12	0.59
amygdala - adult, donor10196	10167-103B5	24.90	29.64	5.93	4.74	1.19	3.56	1.19
amygdala, adult, donor10252	10151-102I7	56.57	32.24	13.79	10.34	0.81	2.84	0.61
amygdala, newborn, donor10223	10360-105E9	29.37	19.04	9.04	8.71	0.32	1.94	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	18.59	20.12	11.21	4.84	1.40	1.15	0.89
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	7.72	11.03	7.94	2.43	1.99	0.22	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	62.80	37.08	5.34	24.72	1.67	1.00	3.34
aorta, adult, pool1	10052-101G7	28.64	24.71	22.95	6.86	0.39	0.59	0.20
appendix, adult	10189-103D9	35.32	28.33	15.14	12.03	1.55	2.72	1.55
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	16.51	17.20	8.94	4.47	2.75	0.34	1.03
artery, adult	10190-103E1	20.38	14.95	24.46	4.08	1.36	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	20.57	22.74	9.56	3.48	0.72	1.01	1.01
b cell line:RPMI1788	10427-106D4	7.29	11.45	10.86	2.23	0.89	0.00	0.74
basal cell carcinoma cell line:TE 354.T	10702-109G9	11.65	22.20	14.98	0.28	0.55	0.55	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	11.11	18.75	13.00	2.68	2.88	1.79	0.89
bile duct carcinoma cell line:TFK-1	10496-107C1	11.38	15.06	10.71	1.34	1.00	0.84	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	7.27	3.91	2.80	1.68	0.00	0.00	0.56
bladder, adult, pool1	10011-101C2	33.79	27.38	22.05	9.45	0.54	0.33	0.54
blood, adult, pool1	10053-101G8	11.07	4.43	17.72	11.07	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	11.13	21.41	7.71	1.71	2.57	0.86	3.43
bone marrow, adult	10192-103E3	32.39	24.29	20.24	10.80	2.02	0.00	0.67
brain, adult, donor1	10084-102B3	32.80	22.55	12.30	7.18	1.03	4.10	0.00
brain, adult, pool1	10012-101C3	30.96	21.38	15.81	9.58	0.89	2.56	0.56
brain, fetal, pool1	10085-102B4	50.76	8.01	0.00	13.36	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	27.42	24.78	28.41	5.95	2.64	1.32	1.32
breast carcinoma cell line:MDA-MB-453	10419-106C5	21.84	30.08	34.33	1.75	1.50	3.87	1.75
breast, adult, donor1	10080-102A8	16.42	18.94	11.36	5.05	0.63	1.26	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	4.83	5.59	3.30	2.54	1.91	1.40	2.03
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	10.51	14.84	12.06	0.93	3.40	0.62	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	6.91	4.14	2.30	1.61	3.91	0.00	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	14.53	14.53	19.61	2.91	1.21	1.21	0.73
carcinoid cell line:NCI-H1770	10703-109H1	16.93	17.87	6.11	1.41	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	14.99	19.36	11.16	1.53	1.97	0.11	0.55
carcinoid cell line:SK-PN-DW	10719-109I8	16.80	11.09	1.90	7.29	0.32	0.00	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	65.75	29.28	10.11	21.03	3.19	1.33	2.13
caudate nucleus - adult, donor10196	10177-103C6	49.51	35.69	8.06	20.72	1.15	2.30	0.00
caudate nucleus, adult, donor10252	10164-103B2	62.58	27.94	10.88	22.59	0.84	3.51	0.50
caudate nucleus, adult, donor10258	10379-105H1	43.56	28.27	6.11	19.87	0.76	4.58	0.00
caudate nucleus, newborn, donor10223	10354-105E3	56.03	32.23	9.89	13.55	1.83	1.83	1.10
cerebellum - adult, donor10196	10173-103C2	142.75	64.09	8.74	37.87	0.00	8.74	0.00
cerebellum, adult, donor10252	10166-103B4	145.19	55.30	14.31	35.66	1.49	5.76	0.00
cerebellum, adult, pool1	10083-102B2	46.22	25.18	4.83	12.42	0.00	1.72	0.00
cerebellum, newborn, donor10223	10357-105E6	108.77	26.57	4.98	39.85	0.83	1.66	0.00
cerebral meninges, adult	10188-103D8	30.76	26.73	15.38	10.34	0.76	3.03	2.02
cerebrospinal fluid, donor2	10294-104G6	5.85	6.58	8.77	2.19	0.73	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	17.40	22.29	5.46	2.30	1.01	0.72	0.29
cervical cancer cell line:ME-180	10553-107I4	15.08	16.24	15.91	1.49	0.17	0.66	0.33
cervix, adult, pool1	10013-101C4	54.28	30.24	18.69	18.69	0.84	1.15	0.52
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	16.44	25.78	15.75	3.20	1.81	1.25	0.70
chondrosarcoma cell line:SW 1353	10700-109G7	14.37	15.68	3.92	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	32.56	27.84	11.18	8.70	1.86	0.99	0.50
choriocarcinoma cell line:SCH	10785-110H2	28.34	29.69	4.93	4.07	0.86	1.23	0.86
choriocarcinoma cell line:T3M-3	10618-108G6	19.21	10.44	2.85	7.35	0.47	0.71	0.00
chorionic membrane cells, donor1	12238-129G6	14.53	20.23	18.52	1.71	1.14	0.57	0.28
chorionic membrane cells, donor2	12239-129G7	16.80	27.14	11.43	2.19	1.39	0.99	0.89
chorionic membrane cells, donor3	12240-129G8	12.64	8.24	12.64	3.85	1.10	0.55	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	4.04	1.01	1.01	0.00	1.01	0.00	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	8.45	8.07	8.64	1.54	0.96	0.19	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	9.50	9.50	9.29	2.75	1.90	0.21	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	16.44	5.91	2.05	7.45	0.51	0.00	0.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	15.24	6.77	3.39	7.74	0.48	0.73	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	16.70	8.76	3.05	6.52	0.81	0.81	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	13.84	7.07	1.77	5.01	1.18	0.88	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	13.55	14.60	5.73	4.17	1.30	0.52	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	16.46	13.71	5.26	4.34	3.89	0.00	0.69
clear cell carcinoma cell line:TEN	10636-108I6	27.76	25.16	18.57	7.11	3.99	3.64	2.78
colon carcinoma cell line:CACO-2	10513-107D9	18.12	10.62	5.86	3.84	2.01	0.73	0.73
colon carcinoma cell line:COLO-320	10420-106C6	31.55	25.47	9.12	9.88	1.52	0.00	0.38
colon, adult, donor1	10082-102B1	19.04	13.09	10.71	3.57	2.38	0.00	2.38
colon, adult, pool1	10014-101C5	23.27	23.03	21.03	6.46	1.29	1.06	0.47
colon, fetal, donor1	10070-101I7	38.93	31.52	10.51	9.27	0.62	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	105.42	77.92	68.75	18.33	4.58	0.00	9.17
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	25.04	25.04	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	20.40	16.57	49.29	4.67	5.95	2.97	4.25
cord blood derived cell line:COBL-a 24h infection	10453-106G3	6.19	7.09	13.13	1.36	5.28	0.45	2.11
cord blood derived cell line:COBL-a untreated	10449-106F8	8.04	7.19	16.08	0.99	2.82	0.28	3.67
corpus callosum, adult, pool1	10042-101F6	46.77	39.80	35.16	11.28	1.44	1.00	0.44
cruciate ligament, donor2	10295-104G7	17.02	17.02	21.88	4.05	0.00	0.00	1.62
diaphragm, fetal, donor1	10069-101I6	27.29	20.06	13.64	8.03	0.00	0.00	0.80
diencephalon, adult	10193-103E4	20.88	15.84	9.84	7.20	0.00	0.96	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	9.41	3.90	6.20	2.07	1.15	0.92	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	33.34	30.00	17.44	9.74	2.56	1.28	0.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	18.54	18.29	10.83	3.37	2.41	0.48	0.48
ductus deferens, adult	10196-103E7	25.42	30.90	19.93	6.48	2.49	1.99	1.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	23.04	21.60	17.28	5.76	0.00	1.44	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	27.95	22.07	7.36	7.36	0.74	1.47	3.68
dura mater, adult, donor1	10041-101F5	31.14	29.57	35.02	11.64	0.99	1.73	0.91
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	49.30	56.41	17.10	8.44	2.66	1.11	0.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	16.77	16.48	5.88	3.73	0.43	0.14	0.72
embryonic pancreas cell line:1B2C6	10604-108F1	10.48	19.73	10.48	5.55	4.32	1.23	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	17.56	12.11	7.57	6.36	1.21	0.61	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	17.29	17.29	11.11	6.48	1.85	1.54	1.54
embryonic pancreas cell line:2C6	10603-108E9	10.51	13.13	2.63	3.94	2.63	0.00	2.63
endometrial carcinoma cell line:OMC-2	10497-107C2	23.13	19.44	9.39	4.02	1.68	0.67	2.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	21.39	23.38	8.16	7.79	1.63	0.36	1.81
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	18.01	9.01	6.43	4.02	1.13	1.93	0.64
epidermoid carcinoma cell line:A431	10426-106D3	15.78	18.90	13.56	2.56	1.56	0.89	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	11.99	15.95	9.57	1.76	1.54	2.20	1.10
epididymis, adult	10197-103E8	22.19	21.77	21.14	6.91	2.09	2.09	1.26
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	15.08	17.74	9.58	4.44	1.95	0.18	1.06
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	21.63	25.17	13.76	5.11	1.97	0.79	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	9.57	8.78	7.08	1.31	1.44	2.49	1.05
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	10.83	11.32	7.28	1.87	2.76	3.15	0.98
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	10.75	8.40	7.06	1.68	2.69	1.79	0.78
esophagus, adult, pool1	10015-101C6	19.64	20.70	18.69	4.67	1.17	1.17	0.64
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	49.09	47.21	26.30	23.54	3.26	2.25	4.76
eye - muscle inferior rectus, donor1	10272-104E2	21.73	14.49	7.24	4.83	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	12.63	12.63	16.83	12.63	0.00	0.00	4.21
eye - muscle medial, donor2	10299-104H2	11.91	8.93	10.42	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	19.49	10.32	12.61	3.44	0.00	1.15	2.29
eye - vitreous humor, donor1	10268-104D7	16.03	37.89	17.49	1.46	0.00	0.00	2.91
eye, fetal, donor1	10054-101G9	38.39	26.69	12.97	7.37	0.51	1.02	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	9.62	9.87	3.33	2.44	1.28	0.13	0.64
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	27.54	25.17	8.31	5.22	4.27	1.42	2.37
frontal lobe, adult, pool1	10040-101F4	41.66	31.52	20.55	12.29	0.75	3.28	0.56
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	13.21	14.71	6.00	2.70	1.50	0.00	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	11.06	19.84	16.82	2.10	3.38	0.73	1.01
gall bladder, adult	10198-103E9	28.25	24.14	20.52	9.17	0.24	1.69	0.48
gamma delta positive T cells, donor1	11937-126A2	41.34	16.64	8.05	8.59	3.76	0.54	3.22
gamma delta positive T cells, donor2	11938-126A3	26.89	20.92	12.33	7.84	1.87	2.24	1.12
gastric adenocarcinoma cell line:MKN1	10614-108G2	13.52	19.64	13.10	2.53	0.84	0.21	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	18.57	14.51	10.83	6.58	0.77	1.16	1.35
gastric cancer cell line:AZ521	10549-107H9	26.07	30.99	11.15	5.74	3.44	0.98	2.62
gastric cancer cell line:GSS	10560-108A2	17.39	9.15	2.75	6.41	1.83	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	23.53	27.87	12.79	3.66	0.69	0.23	0.91
giant cell carcinoma cell line:LU65	10487-107B1	9.52	11.02	6.54	1.84	0.46	0.69	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	28.69	35.83	19.59	5.46	4.62	0.70	1.96
glassy cell carcinoma cell line:HOKUG	10688-109F4	14.47	16.21	9.48	2.99	1.00	0.50	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	23.75	25.65	20.69	6.02	2.74	1.90	1.69
glioblastoma cell line:A172, tech_rep2	10444-106F3	23.87	26.26	20.50	3.65	3.37	1.12	2.53
glioblastoma cell line:T98G	10485-107A8	12.80	20.20	15.34	3.75	3.31	0.33	1.66
glioma cell line:GI-1	10413-106B8	15.52	25.77	13.47	3.51	2.64	0.59	0.29
globus pallidus - adult, donor10196	10175-103C4	37.17	21.14	6.56	9.48	0.73	0.73	0.73
globus pallidus, adult, donor10252	10161-103A8	48.09	34.42	22.94	9.03	0.98	1.95	0.24
globus pallidus, adult, donor10258	10367-105F7	20.54	15.06	19.17	9.58	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	37.84	25.58	17.05	11.72	1.60	1.07	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	85.65	88.10	85.65	26.92	2.45	2.45	7.34
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	0.00	21.86	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	5.23	5.23	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	24.32	22.72	10.56	2.24	1.28	1.28	0.96
hIPS +CCl2, biol_rep1	14383-156B9	15.15	9.18	1.38	4.59	1.38	0.46	0.46
hIPS +CCl2, biol_rep2	14384-156C1	17.38	3.20	0.00	5.94	0.91	0.46	0.91
hIPS +CCl2, biol_rep3	14385-156C2	10.31	7.73	0.64	1.29	1.29	0.00	0.64
hIPS, biol_rep1	14380-156B6	8.62	2.87	1.44	4.31	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	8.23	4.12	1.37	2.74	0.69	0.00	0.69
hIPS, biol_rep3	14382-156B8	30.90	14.35	0.00	9.93	0.00	2.21	1.10
hairy cell leukemia cell line:Mo	10712-109I1	11.78	8.33	8.33	1.72	1.44	0.29	0.29
heart - mitral valve, adult	10205-103F7	27.51	27.80	23.92	5.08	2.09	1.20	1.79
heart - pulmonic valve, adult	10206-103F8	26.41	22.75	20.40	7.06	1.57	1.57	0.52
heart - tricuspid valve, adult	10207-103F9	38.30	37.47	27.48	7.49	0.83	2.50	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	12.04	17.75	15.71	2.45	1.02	0.61	0.00
heart, adult, diseased, donor1	10051-101G6	18.74	11.07	16.18	2.55	0.00	0.85	0.43
heart, adult, pool1	10016-101C7	14.72	16.10	17.02	2.76	1.15	0.23	0.92
heart, fetal, pool1	10046-101G1	50.01	52.26	30.60	8.11	2.98	0.62	2.05
hepatic mesenchymal tumor cell line:LI90	10778-110G4	15.73	27.15	17.28	0.62	2.16	0.00	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	8.32	16.65	7.14	1.19	4.76	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	20.44	13.70	8.18	3.87	1.22	0.66	0.88
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	21.73	14.81	6.68	4.61	1.58	0.85	0.36
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	22.94	17.08	7.07	4.35	1.82	1.11	0.81
hepatoma cell line:Li-7	10484-107A7	20.80	23.47	14.12	3.23	1.33	0.33	0.67
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	3.22	3.72	2.51	0.70	0.50	0.10	0.10
hippocampus - adult, donor10196	10169-103B7	32.18	23.66	7.57	6.62	0.00	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	47.15	28.78	18.57	10.82	1.84	2.04	1.22
hippocampus, adult, donor10258	10374-105G5	26.89	9.96	2.99	6.97	0.00	2.49	0.50
hippocampus, newborn, donor10223	10363-105F3	53.58	22.21	6.70	18.68	0.70	2.47	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	12.21	13.43	1.83	3.05	1.22	1.22	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	24.54	15.90	5.69	7.85	1.77	0.59	0.79
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	17.52	17.01	4.57	4.82	2.29	1.52	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	38.34	29.88	5.07	12.97	1.13	0.56	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	44.93	38.47	8.52	15.23	3.10	0.00	1.55
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	31.89	30.75	3.04	10.25	1.90	0.38	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	28.90	15.47	7.01	7.88	2.04	0.88	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	33.18	27.36	6.68	14.00	2.37	0.43	1.51
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	22.94	22.10	5.42	4.59	0.83	0.83	2.50
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	13.50	15.39	4.74	5.45	1.18	0.24	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	23.14	17.36	5.30	6.11	1.45	0.32	1.61
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	12.79	13.47	4.71	7.41	3.37	0.00	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	27.38	14.71	5.01	6.42	2.03	0.47	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	24.07	18.18	2.95	6.39	0.98	0.00	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	10.47	8.73	5.24	3.49	6.11	0.00	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	57.27	43.91	10.50	12.79	1.91	0.19	2.10
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	40.55	46.22	7.85	10.03	0.87	0.00	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	24.49	16.49	5.00	9.00	1.50	0.50	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	45.03	39.56	8.85	17.14	0.38	0.00	1.32
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	52.29	37.29	7.28	18.19	0.91	0.91	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	33.20	31.01	2.82	10.65	1.25	0.31	1.25
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	20.58	24.33	5.72	6.04	0.65	0.33	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	19.45	15.97	5.23	7.84	0.00	0.58	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	23.91	25.11	6.28	5.68	0.90	0.30	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	21.43	19.21	4.62	6.65	1.85	1.66	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	24.82	15.69	4.28	6.56	1.14	1.43	0.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	15.92	15.11	4.08	6.12	2.04	1.22	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	28.52	27.46	4.93	8.10	1.41	0.35	1.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	26.92	27.87	5.70	6.65	2.85	0.00	1.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	22.70	22.70	6.66	4.84	0.91	0.00	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	21.72	26.37	5.69	7.24	1.55	1.03	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	23.91	17.93	2.66	5.98	0.66	0.66	1.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	14.11	13.34	5.90	7.18	2.05	0.51	2.05
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	17.13	15.34	4.35	4.86	1.02	1.02	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	18.17	22.72	4.54	4.54	0.76	0.00	3.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	13.44	16.47	5.38	4.37	3.02	0.34	1.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	21.98	16.42	1.93	6.28	0.48	0.48	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	10.25	12.48	2.67	5.35	2.23	2.23	2.23
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	15.61	21.46	5.85	6.34	0.98	0.49	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	39.42	29.95	4.89	10.09	2.44	0.31	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	16.27	22.77	13.01	9.76	3.25	0.00	9.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	25.15	19.86	4.96	6.95	3.31	0.00	2.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	36.67	17.51	4.38	7.66	0.55	0.00	2.74
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	26.06	19.18	5.07	6.15	0.72	0.00	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	23.49	14.59	3.91	8.90	2.49	0.36	1.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	22.67	11.93	2.39	11.93	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	19.09	18.15	5.28	6.09	1.49	0.27	0.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	14.01	15.62	3.50	2.96	0.27	0.00	0.81
immature langerhans cells, donor1	11904-125F5	19.13	31.48	40.20	2.91	0.97	0.97	0.97
immature langerhans cells, donor2	11905-125F6	56.24	49.11	40.40	8.71	0.79	6.34	0.79
insula, adult, pool1	10039-101F3	45.33	40.98	21.86	14.01	1.99	3.79	1.32
keratoacanthoma cell line:HKA-1	10791-110H8	8.78	13.01	7.15	3.25	0.98	1.30	0.00
kidney, adult, pool1	10017-101C8	23.43	22.93	20.23	4.41	2.00	1.20	1.50
kidney, fetal, pool1	10045-101F9	46.76	41.88	19.17	9.41	2.26	0.99	1.49
large cell lung carcinoma cell line:IA-LM	10509-107D5	49.71	47.15	13.78	11.50	9.52	1.85	4.83
large cell lung carcinoma cell line:NCI-H460	10839-111E2	8.16	8.71	5.81	2.07	1.38	0.69	0.69
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	23.30	21.47	8.26	6.06	0.92	1.65	0.18
left atrium, adult, donor1	10079-102A7	12.53	6.54	6.54	2.18	0.54	0.54	1.09
left ventricle, adult, donor1	10078-102A6	9.61	6.07	6.57	2.02	0.51	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	16.42	18.06	10.12	4.92	0.82	0.55	0.82
leiomyoma cell line:10964C	10569-108B2	8.98	7.90	3.59	1.08	0.36	1.80	0.00
leiomyoma cell line:15242A	10570-108B3	8.70	3.80	4.89	2.72	0.00	1.63	0.00
leiomyoma cell line:15425	10571-108B4	9.96	7.77	5.34	2.67	1.70	0.97	1.21
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	25.40	19.05	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	19.87	21.96	12.55	6.27	3.14	1.05	3.14
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	16.41	20.90	10.63	3.19	1.06	0.24	0.47
liposarcoma cell line:KMLS-1	10782-110G8	13.59	19.37	12.97	2.81	1.72	1.41	1.09
liposarcoma cell line:SW 872	10726-110A6	29.97	32.29	16.69	5.24	5.36	1.10	1.58
liver, adult, pool1	10018-101C9	11.02	12.32	11.99	0.97	1.94	0.65	0.65
liver, fetal, pool1	10086-102B5	9.41	19.75	3.76	2.82	0.00	0.00	0.94
locus coeruleus - adult, donor10196	10182-103D2	38.35	28.58	12.10	6.42	1.17	1.75	0.29
locus coeruleus, adult, donor10252	10165-103B3	38.57	28.79	13.66	6.09	1.29	1.66	0.55
locus coeruleus, adult, donor10258	10375-105G6	25.11	18.34	5.36	5.36	1.13	1.41	0.00
locus coeruleus, newborn, donor10223	10362-105F2	23.13	14.72	10.09	7.57	1.26	0.84	1.26
lung adenocarcinoma cell line:A549	10499-107C4	11.90	14.39	8.86	2.21	1.52	0.69	0.97
lung adenocarcinoma cell line:PC-14	10408-106B3	11.03	15.86	11.03	0.00	3.45	0.00	1.38
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	6.06	7.91	7.25	0.79	1.05	0.00	0.66
lung, adult, pool1	10019-101D1	28.00	26.70	24.22	5.91	2.13	0.35	1.30
lung, fetal, donor1	10068-101I5	94.76	61.08	19.12	31.11	3.14	0.86	4.28
lung, right lower lobe, adult, donor1	10075-102A3	27.03	22.45	15.58	5.96	2.29	1.83	0.92
lymph node, adult, donor1	10077-102A5	25.09	16.57	8.52	6.15	2.37	0.95	0.47
lymphangiectasia cell line:DS-1	10727-110A7	6.14	11.62	7.89	2.85	1.53	0.22	1.32
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	14.94	11.47	9.51	4.38	3.77	0.15	2.26
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	22.94	28.03	11.89	5.95	1.70	0.85	0.85
mature adipocyte, donor1	12231-129F8	30.19	32.41	36.85	4.44	0.44	1.78	0.00
mature adipocyte, donor2	12232-129F9	45.03	39.02	36.52	5.81	0.83	1.66	0.21
mature adipocyte, donor3	12233-129G1	38.40	31.53	29.87	4.98	1.42	1.66	0.47
mature adipocyte, donor4	12234-129G2	30.53	30.80	35.27	3.95	0.53	0.79	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	21.44	30.50	16.20	6.43	3.57	3.10	1.43
medial frontal gyrus - adult, donor10196	10170-103B8	33.84	32.71	5.64	4.51	0.00	3.38	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	57.56	35.68	16.00	11.95	1.47	2.94	0.74
medial frontal gyrus, adult, donor10258	10368-105F8	20.97	11.44	2.54	4.45	0.32	1.59	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	39.66	17.49	10.66	9.38	2.99	0.43	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	49.44	26.83	12.32	11.48	0.51	1.01	0.84
medial temporal gyrus, adult, donor10252	10156-103A3	55.39	30.98	19.95	10.40	1.27	2.76	0.85
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	7.71	21.19	0.00	5.78	0.00	3.85	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	0.00	28.71	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	36.25	16.87	6.82	7.54	1.08	2.51	0.36
medulla oblongata - adult, donor10196	10174-103C3	29.20	18.17	6.49	5.19	0.00	1.30	1.30
medulla oblongata, adult, donor10252	10155-103A2	44.27	28.17	18.73	8.36	0.62	2.63	0.77
medulla oblongata, adult, pool1	10038-101F2	38.28	32.08	22.94	9.31	1.06	2.12	0.73
medulla oblongata, newborn, donor10223	10361-105F1	36.45	23.96	8.68	6.25	1.04	1.39	0.35
medulloblastoma cell line:D283 Med	10838-111E1	32.33	30.11	6.64	12.40	1.11	0.00	1.55
medulloblastoma cell line:ONS-76	10759-110E3	15.16	17.97	6.24	2.57	2.08	0.61	0.98
melanoma cell line:COLO 679	10514-107E1	12.65	17.82	13.94	4.60	2.16	0.14	1.58
melanoma cell line:G-361	10465-106H6	9.23	10.86	9.50	3.26	1.36	0.54	0.27
meningioma cell line:HKBMM	10691-109F7	8.86	10.49	6.51	3.08	0.90	0.18	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	32.60	28.20	14.98	19.39	0.88	0.00	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	15.03	12.44	5.18	7.00	1.04	0.00	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	10.43	10.13	4.60	2.15	1.07	0.46	0.92
mesenchymal precursor cell - adipose, donor2	11748-123G2	10.36	8.73	6.91	2.18	0.18	0.18	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	8.70	2.48	4.14	2.48	0.41	0.00	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	8.43	6.60	5.48	1.40	0.70	0.70	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	12.13	10.98	4.43	2.12	0.58	0.77	0.77
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	13.88	13.88	6.25	3.47	0.69	0.69	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	5.84	7.21	5.84	1.20	0.17	1.03	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	10.35	11.96	8.86	1.96	0.92	1.27	0.58
mesenchymal precursor cell - cardiac, donor3	11754-123G8	10.21	9.42	5.04	1.46	0.53	0.53	0.93
mesenchymal precursor cell - cardiac, donor4	11755-123G9	12.15	12.29	9.05	1.62	1.08	0.27	0.81
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	14.37	12.66	6.40	1.99	1.56	0.71	0.57
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	8.23	13.83	7.58	3.29	1.32	0.00	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	11.76	14.39	7.89	2.35	2.21	0.42	1.38
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	10.82	10.47	10.82	1.05	2.44	1.75	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	7.15	8.57	6.12	0.82	0.20	0.20	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	17.61	16.53	10.78	1.08	1.08	0.00	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	9.52	10.86	5.07	1.45	0.93	0.62	0.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	12.54	13.68	9.35	2.51	0.68	1.60	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	10.91	9.23	4.20	2.94	2.10	0.42	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	9.56	12.70	7.02	1.79	1.34	0.30	1.34
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	11.47	11.38	6.13	1.93	0.96	0.96	0.96
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	13.25	16.20	11.78	0.74	0.74	1.10	1.84
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	17.46	20.89	13.45	2.29	2.00	1.72	1.14
mesenchymal stem cell line:Hu5/E18	10568-108B1	9.68	14.31	8.84	2.53	1.26	0.84	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	8.68	11.42	1.37	2.28	0.46	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	7.67	8.70	3.84	2.56	0.26	0.51	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	10.99	11.52	5.76	2.88	0.00	1.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	12.63	10.17	4.62	2.16	0.92	1.23	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	11.77	8.00	4.71	2.59	0.24	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	10.49	6.43	5.42	1.69	1.35	2.03	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	9.04	9.43	2.75	1.96	0.00	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	8.34	5.56	4.63	3.24	0.46	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	11.25	11.83	6.63	3.75	1.15	2.02	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	9.37	9.59	4.46	2.90	0.00	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	11.06	9.13	6.25	2.16	0.72	0.48	0.96
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	19.80	18.33	8.80	2.20	2.20	3.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	7.05	7.72	3.69	3.02	1.01	0.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	12.69	11.46	5.73	2.46	0.41	0.41	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	12.89	9.45	3.87	1.29	0.00	1.72	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	13.67	2.73	8.20	5.47	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	7.15	6.17	5.85	1.95	0.32	1.30	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	5.82	5.82	4.36	4.36	0.00	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	15.46	11.73	5.86	1.07	0.53	1.60	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	9.00	9.00	4.91	3.27	1.64	0.82	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	11.66	6.61	5.05	2.33	0.78	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	6.30	10.49	2.10	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	10.93	13.91	3.97	1.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	9.53	4.77	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	7.12	5.93	4.74	2.37	0.00	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	10.97	15.84	8.53	3.66	3.66	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	8.87	10.77	3.80	4.43	0.63	1.90	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	12.76	10.35	4.14	2.76	0.34	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	4.30	10.75	2.15	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	7.98	0.00	3.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	0.00	6.89	0.00	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	6.11	4.89	1.63	2.04	0.81	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	7.94	6.36	3.18	1.59	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	5.90	6.48	2.36	1.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	4.68	6.23	2.18	1.56	0.62	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	8.02	6.68	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	7.10	3.55	1.18	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	10.27	2.57	10.27	2.57	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	9.64	7.57	2.07	2.07	0.69	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	5.44	9.90	4.45	1.48	1.98	0.49	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	6.73	4.49	4.49	0.00	0.00	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	5.72	10.81	2.54	0.64	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	4.43	7.25	2.82	1.61	0.00	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	8.72	2.18	2.18	0.00	0.00	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	1.27	3.80	2.53	2.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	8.50	10.92	6.07	1.21	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	9.04	9.04	0.00	4.52	0.00	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	7.41	9.88	6.59	1.65	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	6.94	5.95	2.78	2.18	0.60	0.79	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	11.03	6.17	3.89	0.97	0.00	0.00	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	11.20	9.17	10.19	6.11	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	23.99	26.31	14.70	3.87	0.77	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	30.00	38.27	17.72	8.27	1.18	1.18	0.94
mesothelioma cell line:ACC-MESO-4	10494-107B8	21.78	24.56	21.55	5.79	2.78	0.23	3.24
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	12.82	17.09	12.82	4.27	0.00	0.00	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	8.63	9.97	6.27	1.23	2.16	0.62	0.82
mesothelioma cell line:Mero-25	10850-111F4	16.57	11.80	4.99	3.86	0.45	1.13	0.45
mesothelioma cell line:Mero-41	10851-111F5	12.47	10.27	9.05	3.18	0.49	0.49	0.73
mesothelioma cell line:Mero-48a	10852-111F6	21.48	15.06	5.76	3.99	1.11	0.89	1.11
mesothelioma cell line:Mero-82	10853-111F7	22.60	23.92	17.61	2.89	1.05	1.31	0.26
mesothelioma cell line:Mero-83	10854-111F8	18.38	16.34	9.19	2.89	2.21	1.19	1.02
mesothelioma cell line:Mero-84	10855-111F9	14.16	6.57	3.03	2.27	0.76	0.76	0.00
mesothelioma cell line:Mero-95	10856-111G1	18.43	16.36	7.66	5.18	1.66	1.24	0.83
mesothelioma cell line:NCI-H2052	10847-111F1	15.07	15.24	6.13	3.64	1.82	0.50	0.66
mesothelioma cell line:NCI-H226	10846-111E9	11.95	9.95	7.06	3.08	1.09	1.27	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	12.98	10.08	10.93	3.59	0.85	2.05	1.20
mesothelioma cell line:NCI-H28	10845-111E8	20.61	15.27	8.14	6.36	2.29	1.53	1.78
mesothelioma cell line:No36	10857-111G2	12.07	6.52	3.91	2.94	1.63	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	15.17	11.92	13.28	2.44	0.81	0.54	0.27
migratory langerhans cells, donor1	11901-125F2	14.01	13.05	11.13	2.69	1.34	0.00	1.54
migratory langerhans cells, donor2	11902-125F3	14.04	11.72	11.48	2.44	3.30	0.12	2.08
migratory langerhans cells, donor3	11903-125F4	13.28	12.74	15.79	1.44	2.87	0.36	1.08
mixed mullerian tumor cell line:HTMMT	10689-109F5	21.55	28.73	11.43	3.92	0.65	0.65	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	8.90	10.38	5.72	2.33	0.85	0.64	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	14.28	22.11	11.75	3.23	0.69	2.30	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	6.85	7.99	7.04	0.95	0.76	0.00	1.52
myelodysplastic syndrome cell line:SKM-1	10772-110F7	4.44	6.10	5.91	2.59	0.18	0.00	0.74
myeloma cell line:PCM6	10474-106I6	2.77	5.14	7.31	0.40	0.59	0.00	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	7.61	9.64	9.64	1.52	3.55	0.00	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	4.90	9.81	10.98	0.78	0.39	0.98	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	10.36	16.71	7.02	1.56	0.11	0.56	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	8.97	12.06	6.10	2.72	0.51	0.74	0.15
nasal epithelial cells, donor2	12227-129F4	8.28	17.66	12.70	2.21	0.00	1.10	1.10
neuroblastoma cell line:CHP-134	10508-107D4	44.40	41.41	12.88	12.88	0.92	0.23	2.53
neuroblastoma cell line:NB-1	10539-107G8	39.10	43.78	14.41	9.17	4.49	2.06	3.55
neuroblastoma cell line:NBsusSR	10607-108F4	18.35	16.66	5.06	7.38	0.84	0.63	0.21
neuroblastoma cell line:NH-12	10555-107I6	42.67	32.61	8.39	8.57	0.93	0.37	2.42
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	37.48	17.32	1.42	21.11	0.95	0.24	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	38.01	20.75	3.96	16.47	0.63	0.95	1.58
neuroectodermal tumor cell line:TASK1	10774-110F9	16.10	13.48	2.01	5.43	0.20	0.20	0.60
neuroepithelioma cell line:SK-N-MC	10728-110A8	42.60	10.81	1.91	24.16	0.64	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	17.83	19.70	10.38	1.60	1.06	0.00	0.53
neutrophil PMN, donor1	12133-128D9	133.87	178.50	193.37	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	39.84	26.56	66.40	26.56	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	56.82	28.41	9.47	0.00	0.00	9.47
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	31.12	25.20	22.49	7.44	2.37	0.17	4.06
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	12.01	12.01	5.60	0.80	0.80	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	16.03	20.84	9.62	4.17	0.96	2.24	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	8.93	11.04	7.62	2.10	1.31	0.26	0.53
nucleus accumbens, adult, pool1	10037-101F1	56.62	41.43	19.78	19.87	0.94	4.87	1.22
occipital cortex - adult, donor10196	10172-103C1	72.11	32.97	10.30	12.36	0.00	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	57.16	36.77	19.59	11.00	1.34	1.34	0.54
occipital cortex, newborn, donor10223	10355-105E4	45.86	25.84	8.01	11.28	0.73	1.09	0.36
occipital lobe, adult, donor1	10076-102A4	30.18	25.72	10.76	10.76	1.05	2.89	0.26
occipital lobe, fetal, donor1	10073-102A1	82.82	36.04	3.00	38.19	0.00	0.86	0.86
occipital pole, adult, pool1	10036-101E9	32.64	22.39	13.40	8.67	0.47	2.37	0.39
olfactory region, adult	10195-103E6	40.50	18.53	8.22	9.17	0.38	1.34	0.57
optic nerve, donor1	10277-104E7	40.02	36.02	20.01	10.01	0.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	17.54	26.43	15.49	3.65	1.03	2.51	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	9.34	8.11	7.01	3.43	0.41	0.41	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	18.96	17.44	9.65	3.22	2.54	1.19	0.51
oral squamous cell carcinoma cell line:SAS	10544-107H4	12.82	10.97	10.63	2.08	0.81	1.27	0.46
osteoclastoma cell line:Hs 706.T	10704-109H2	17.64	23.52	17.93	2.94	0.29	0.59	1.18
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	14.95	13.08	14.02	1.87	3.74	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	13.15	18.87	9.33	6.15	0.85	0.21	1.91
ovary, adult, pool1	10020-101D2	58.26	33.19	12.23	19.65	1.05	1.57	0.61
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	11.73	15.40	4.40	0.73	1.28	1.47	0.37
pancreas, adult, donor1	10049-101G4	15.05	24.46	11.29	4.70	1.88	0.94	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	36.90	32.43	8.11	6.43	1.12	1.40	1.68
papillary adenocarcinoma cell line:8505C	10437-106E5	12.95	11.92	9.71	2.04	1.53	0.85	0.68
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	16.39	15.90	13.25	2.15	2.32	0.33	0.50
paracentral gyrus, adult, pool1	10035-101E8	37.80	31.30	16.02	11.35	0.46	2.47	0.55
parietal cortex, adult, donor10258	10373-105G4	37.43	7.34	0.73	12.48	0.73	1.47	3.67
parietal lobe - adult, donor10196	10171-103B9	31.04	12.23	15.99	9.40	0.94	1.88	0.94
parietal lobe, adult, donor10252	10157-103A4	56.44	30.21	12.26	6.56	1.43	1.71	1.71
parietal lobe, adult, pool1	10034-101E7	37.63	32.43	18.59	9.08	0.53	3.79	0.70
parietal lobe, fetal, donor1	10072-101I9	86.32	38.79	3.88	40.73	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	42.25	28.79	13.83	10.47	1.50	1.12	0.37
parotid gland, adult	10199-103F1	20.35	17.27	19.73	1.85	0.00	1.85	0.62
penis, adult	10200-103F2	28.47	20.41	24.71	9.13	0.54	1.07	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	68.61	11.90	0.37	48.72	0.19	0.19	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	13.55	20.11	12.09	3.50	2.48	1.46	0.73
pineal gland - adult, donor10196	10179-103C8	46.44	48.38	21.93	3.87	1.29	1.94	2.58
pineal gland, adult, donor10252	10160-103A7	68.10	80.54	35.53	8.29	1.18	2.37	0.59
pineal gland, adult, donor10258	10377-105G8	29.47	24.46	11.91	6.27	0.00	3.14	0.63
pituitary gland - adult, donor10196	10180-103C9	68.80	105.23	17.20	14.17	4.05	0.00	2.02
pituitary gland, adult, donor10252	10162-103A9	109.97	119.87	31.79	25.54	4.17	10.94	5.21
pituitary gland, adult, donor10258	10378-105G9	35.75	30.64	19.58	11.92	1.70	6.81	0.00
placenta, adult, pool1	10021-101D3	17.95	21.82	20.32	4.52	1.94	1.61	0.75
plasma cell leukemia cell line:ARH-77	10840-111E3	8.61	9.80	6.09	1.46	0.26	0.53	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	19.30	16.19	20.54	2.96	1.71	0.00	1.09
pons, adult, pool1	10033-101E6	25.13	23.07	19.45	6.71	0.60	3.01	0.60
postcentral gyrus, adult, pool1	10032-101E5	35.13	25.37	15.17	7.67	0.61	2.09	0.26
promyelocytes/myelocytes PMC, donor1	12132-128D8	29.28	66.92	58.56	8.37	2.09	0.00	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	0.00	11.02	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	11.74	11.74	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	8.16	9.03	7.43	3.35	2.77	0.44	1.60
prostate cancer cell line:PC-3	10439-106E7	9.98	13.43	7.26	3.45	2.54	1.45	1.09
prostate, adult, pool1	10022-101D4	32.20	24.49	18.68	9.16	1.90	1.54	0.54
putamen, adult, donor10196	10176-103C5	94.19	38.01	13.46	40.60	0.94	4.49	1.65
putamen, adult, donor10252	10152-102I8	41.18	29.41	13.73	13.73	0.00	3.92	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	22.95	14.21	0.00	14.21	0.00	5.46	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	49.29	23.92	5.07	28.27	0.00	4.83	0.24
putamen, newborn, donor10223	10365-105F5	20.99	19.49	9.75	6.75	0.75	0.75	1.50
rectal cancer cell line:TT1TKB	10469-106I1	27.93	19.78	8.44	5.82	0.87	2.04	0.58
rectum, fetal, donor1	10067-101I4	36.17	29.21	4.17	9.74	4.17	1.39	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	8.27	9.12	17.17	4.24	2.12	0.42	0.85
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	23.20	16.57	15.33	4.14	0.41	0.00	0.83
retina, adult, pool1	10030-101E3	51.09	43.34	23.96	12.42	1.79	1.99	0.89
retinoblastoma cell line:Y79	10475-106I7	14.55	20.52	7.53	5.20	0.52	0.52	1.56
rhabdomyosarcoma cell line:KYM-1	10787-110H4	10.20	15.00	9.47	3.81	3.93	0.74	1.72
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	26.71	26.71	13.22	6.47	3.66	0.00	2.25
sacrococcigeal teratoma cell line:HTST	10695-109G2	15.16	21.22	10.61	2.27	0.00	0.76	0.00
salivary acinar cells, donor1	11771-123I7	10.36	16.02	11.33	2.10	0.32	0.49	0.65
salivary acinar cells, donor2	11772-123I8	13.63	20.38	13.08	2.75	0.55	0.14	0.41
salivary acinar cells, donor3	11773-123I9	23.17	36.41	15.23	4.63	1.99	0.66	0.00
salivary gland, adult, pool1	10093-102C3	20.59	13.73	8.58	2.86	0.57	1.14	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	30.52	31.36	15.09	11.80	2.11	4.72	1.35
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	26.21	27.62	15.16	9.52	2.12	5.29	2.00
seminal vesicle, adult	10201-103F3	41.80	25.92	19.58	8.99	4.23	2.12	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	16.76	22.83	20.89	1.70	0.97	1.21	1.46
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	10.82	12.08	6.29	1.51	1.01	0.25	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	12.04	12.04	5.02	1.00	2.01	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	42.18	29.42	15.31	4.30	0.81	0.00	0.81
signet ring carcinoma cell line:Kato III	10436-106E4	15.69	20.34	16.69	3.21	0.44	1.11	0.55
signet ring carcinoma cell line:NUGC-4	10483-107A6	9.03	8.26	8.00	1.29	2.58	0.39	1.29
skeletal muscle - soleus muscle, donor1	10282-104F3	3.55	6.38	14.90	1.42	1.42	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	22.67	23.99	40.06	3.48	1.20	0.24	0.24
skeletal muscle, fetal, donor1	10066-101I3	15.08	16.08	5.03	3.02	1.01	0.00	2.01
skin, adult, donor1	10074-102A2	6.79	6.79	13.57	13.57	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	30.93	17.04	11.36	15.15	4.42	0.00	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	18.01	23.68	9.67	4.67	3.34	0.00	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	18.28	20.80	5.67	3.47	0.63	0.00	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	31.61	32.38	6.55	17.54	0.77	1.35	2.12
small cell lung carcinoma cell line:LK-2	10541-107H1	16.98	16.65	11.70	3.30	2.80	0.16	1.15
small cell lung carcinoma cell line:NCI-H82	10842-111E5	20.91	18.98	8.53	4.83	0.16	0.16	0.64
small cell lung carcinoma cell line:WA-hT	10562-108A4	16.13	18.09	8.93	1.96	1.31	0.44	1.53
small intestine, adult, pool1	10024-101D6	20.78	21.74	31.29	4.18	1.31	1.43	0.84
small intestine, fetal, donor1	10064-101I1	18.18	13.02	12.04	4.91	0.98	0.49	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	9.75	8.72	8.21	1.54	1.03	0.51	0.51
smooth muscle, adult, pool1	10048-101G3	33.60	20.93	15.77	4.65	0.26	0.78	0.26
somatostatinoma cell line:QGP-1	10781-110G7	21.98	32.16	28.95	2.14	4.82	1.88	1.07
spinal cord - adult, donor10196	10181-103D1	33.03	21.79	13.08	8.03	0.69	0.46	1.15
spinal cord, adult, donor10252	10159-103A6	35.88	27.20	21.29	5.91	1.58	1.58	0.39
spinal cord, adult, donor10258	10369-105F9	17.99	4.84	1.38	3.46	0.69	0.69	2.08
spinal cord, fetal, donor1	10056-101H2	34.76	30.49	11.59	11.59	1.22	1.22	0.00
spinal cord, newborn, donor10223	10359-105E8	30.31	17.45	9.64	5.97	1.38	1.84	1.38
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	16.88	19.42	12.70	1.79	1.49	1.05	0.60
spleen, adult, pool1	10025-101D7	18.61	21.04	13.44	5.62	3.52	0.99	1.32
spleen, fetal, pool1	10044-101F8	26.30	28.52	14.94	7.15	4.69	0.56	2.15
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	5.38	3.73	3.93	0.93	0.62	0.00	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	14.43	19.75	11.58	2.85	0.76	1.33	1.33
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	12.23	17.47	10.13	4.19	0.35	0.00	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	16.81	34.40	17.59	2.74	1.56	0.78	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	16.66	30.62	18.57	3.71	1.13	1.80	0.56
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	3.81	3.39	2.97	2.12	0.00	0.85	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	9.73	13.12	12.27	3.38	4.23	0.85	1.69
stomach, fetal, donor1	10062-101H8	22.43	34.18	27.77	3.20	0.00	1.07	2.14
submaxillary gland, adult	10202-103F4	24.50	23.36	28.48	7.41	1.14	1.71	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	36.97	30.33	19.32	4.57	1.25	1.25	0.42
substantia nigra, adult, donor10258	10371-105G2	21.72	7.76	2.59	5.69	0.00	2.59	0.00
substantia nigra, newborn, donor10223	10358-105E7	37.45	19.78	14.13	7.77	0.71	0.00	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	28.20	18.57	8.71	11.23	2.52	0.92	1.83
temporal lobe, adult, pool1	10031-101E4	32.21	25.52	15.09	9.07	0.59	2.97	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	69.80	44.87	2.14	34.19	1.42	0.71	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	81.75	31.21	2.20	44.39	0.88	0.44	0.44
tenocyte, donor1	11763-123H8	12.92	6.63	3.49	3.49	0.35	0.35	0.35
tenocyte, donor2	11765-123I1	9.16	10.30	1.91	1.91	0.00	0.76	0.00
tenocyte, donor3	11768-123I4	10.01	6.67	2.22	2.97	0.74	0.37	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	32.80	31.95	12.24	7.65	3.40	0.68	1.36
teratocarcinoma cell line:NCR-G1	10798-110I6	25.28	21.58	5.86	4.32	1.08	0.15	0.62
teratocarcinoma cell line:PA-1	10807-111A6	17.51	16.43	5.42	4.49	2.01	0.31	1.24
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	34.91	29.83	8.00	8.51	3.05	1.02	0.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	30.25	19.29	4.16	10.59	1.89	1.13	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	48.42	40.35	13.09	14.61	4.80	1.42	2.40
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	11.73	5.54	0.98	7.17	0.65	0.33	0.00
testis, adult, pool1	10026-101D8	25.45	25.13	14.50	9.56	1.07	6.23	0.32
testis, adult, pool2	10096-102C6	31.58	16.24	11.28	16.24	1.35	18.04	0.45
thalamus - adult, donor10196	10168-103B6	37.54	16.56	13.25	6.62	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	55.48	32.51	26.10	7.97	0.94	1.41	1.09
thalamus, adult, donor10258, tech_rep1	10370-105G1	18.48	7.70	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	19.27	14.49	5.43	5.27	0.66	2.31	0.00
thalamus, newborn, donor10223	10366-105F6	20.71	9.21	5.75	4.03	0.58	2.88	0.58
throat, adult	10209-103G2	18.97	22.97	20.47	6.74	0.50	1.75	0.50
throat, fetal, donor1	10061-101H7	27.73	23.46	13.41	11.88	0.91	1.52	1.83
thymic carcinoma cell line:Ty-82	10803-111A2	39.95	12.12	1.19	22.26	0.79	0.79	1.79
thymus, adult, pool1	10027-101D9	51.40	15.01	5.77	30.22	2.49	1.29	3.58
thymus, fetal, pool1	10043-101F7	59.33	39.07	11.33	25.04	4.99	0.42	4.05
thyroid carcinoma cell line:KHM-5M	10776-110G2	10.90	8.11	9.17	1.86	2.93	0.00	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	16.48	22.21	10.48	3.07	1.96	0.70	1.12
thyroid, adult, pool1	10028-101E1	32.01	30.23	18.66	4.76	1.68	1.49	1.03
thyroid, fetal, donor1	10060-101H6	48.25	27.68	12.92	11.60	1.58	1.32	1.85
tongue epidermis (fungiform papillae), donor1	10288-104F9	15.40	9.24	3.08	0.00	0.00	0.00	3.08
tongue, adult	10203-103F5	14.42	15.82	18.37	3.72	0.70	0.93	0.23
tongue, fetal, donor1	10059-101H5	21.28	14.98	12.61	3.15	1.18	0.39	0.39
tonsil, adult, pool1	10047-101G2	27.45	27.15	20.74	9.12	2.30	2.70	2.00
trachea, adult, pool1	10029-101E2	20.53	22.17	20.20	5.81	2.37	1.23	0.82
trachea, fetal, donor1	10058-101H4	30.01	22.31	12.69	11.16	2.31	1.15	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	10.27	14.53	12.05	3.54	0.00	1.06	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	17.63	20.67	11.85	2.74	2.94	1.01	0.51
transitional-cell carcinoma cell line:JMSU1	10492-107B6	26.17	21.62	7.83	12.22	3.45	0.47	1.41
tridermal teratoma cell line:HGRT	10694-109G1	17.12	22.83	9.51	3.81	0.00	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	18.79	23.79	11.60	3.89	3.30	0.59	1.10
umbilical cord, fetal, donor1	10057-101H3	25.04	22.95	12.52	4.17	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	65.86	25.08	6.31	20.65	0.85	2.56	1.37
uterus, fetal, donor1	10055-101H1	31.74	21.50	6.66	11.26	0.51	0.51	2.05
vagina, adult	10204-103F6	31.66	20.68	15.51	9.05	1.94	1.29	0.65
vein, adult	10191-103E2	31.35	21.70	15.56	9.86	1.97	0.88	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	4.81	3.74	2.94	0.53	0.53	0.80	0.27